Discussion	NN	B-NP	O	Other	###	1	Discussion	Discussion	NN	NN	_	0	root	_	_

IL-17	NN	B-NP	B-protein	B-Protein	###	1	IL-17	IL-17	NN	NN	_	4	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	2	was	was	VBD	VBD	_	4	auxpass	_	_
first	RB	I-VP	O	Other	###	3	first	first	RB	RB	_	4	advmod	_	_
described	VBN	I-VP	O	Other	###	4	described	described	VBN	VBN	_	0	root	_	_
as	IN	B-PP	O	Other	###	5	as	as	IN	IN	_	9	case	_	_
a	DT	B-NP	O	Other	###	6	a	a	DT	DT	_	9	det	_	_
T	NN	I-NP	B-protein	Other	###	7	T	T	NN	NN	_	9	compound	_	_
cell	NN	I-NP	I-protein	Other	###	8	cell	cell	NN	NN	_	9	compound	_	_
product	NN	I-NP	I-protein	Other	###	9	product	product	NN	NN	_	4	nmod	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	12	case	_	_
proinflammatory	JJ	B-NP	B-protein	Other	###	11	proinflammatory	proinflammatory	JJ	JJ	_	12	amod	_	_
properties	NNS	I-NP	I-protein	Other	###	12	properties	properties	NNS	NNS	_	9	nmod	_	_
[	(	O	I-protein	Other	###	13	[	[	(	(	_	4	advcl	_	_
5	CD	B-NP	I-protein	Other	###	14	5	5	CD	CD	_	13	dobj	_	_
,	,	I-NP	O	Other	###	15	,	,	,	,	_	13	punct	_	_
22	CD	I-NP	O	Other	###	16	22	22	CD	CD	_	17	nummod	_	_
]	)	O	O	Other	###	17	]	]	)	)	_	13	xcomp	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	4	punct	_	_

RA	NN	B-NP	O	Other	###	1	RA	RA	NN	NN	_	3	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	2	is	is	VBZ	VBZ	_	3	auxpass	_	_
characterized	VBN	I-VP	O	Other	###	3	characterized	characterized	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	4	by	by	IN	IN	_	5	case	_	_
hyperplasia	NN	B-NP	O	Other	###	5	hyperplasia	hyperplasia	NN	NN	_	3	nmod	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	9	case	_	_
synovial	JJ	B-NP	B-cell_type	Other	###	7	synovial	synovial	JJ	JJ	_	9	amod	_	_
lining	JJ	I-NP	I-cell_type	Other	###	8	lining	lining	JJ	JJ	_	9	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	###	9	cells	cells	NNS	NNS	_	5	nmod	_	_
and	CC	O	O	Other	###	10	and	and	CC	CC	_	3	cc	_	_
an	DT	B-NP	O	Other	###	11	an	an	DT	DT	_	13	det	_	_
intense	JJ	I-NP	O	Other	###	12	intense	intense	JJ	JJ	_	13	amod	_	_
infiltration	NN	I-NP	O	Other	###	13	infiltration	infiltration	NN	NN	_	17	nsubj	_	_
by	IN	B-PP	O	Other	###	14	by	by	IN	IN	_	16	case	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	###	15	mononuclear	mononuclear	JJ	JJ	_	16	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	###	16	cells	cells	NNS	NNS	_	13	nmod	_	_
[	(	O	O	Other	###	17	[	[	(	(	_	3	conj	_	_
23	CD	B-NP	O	Other	###	18	23	23	CD	CD	_	19	nummod	_	_
]	)	O	O	Other	###	19	]	]	)	)	_	17	xcomp	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	3	punct	_	_

Proinflammatory	JJ	B-NP	B-protein	B-Protein	###	1	Proinflammatory	Proinflammatory	JJ	JJ	_	2	amod	_	_
cytokines	NNS	I-NP	I-protein	I-Protein	###	2	cytokines	cytokines	NNS	NNS	_	9	nsubj	_	_
such	JJ	B-PP	O	Other	###	3	such	such	JJ	JJ	_	5	case	_	_
as	IN	I-PP	O	Other	###	4	as	as	IN	IN	_	3	mwe	_	_
IL-1	NN	B-NP	B-protein	B-Protein	###	5	IL-1	IL-1	NN	NN	_	2	nmod	_	_
and	CC	I-NP	O	Other	###	6	and	and	CC	CC	_	5	cc	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	###	7	TNF-alpha	TNF-alpha	NN	NN	_	5	conj	_	_
are	VBP	B-VP	O	Other	###	8	are	are	VBP	VBP	_	9	cop	_	_
abundant	JJ	B-ADJP	O	Other	###	9	abundant	abundant	JJ	JJ	_	0	root	_	_
in	IN	B-PP	O	Other	###	10	in	in	IN	IN	_	12	case	_	_
rheumatoid	JJ	B-NP	O	Other	###	11	rheumatoid	rheumatoid	JJ	JJ	_	12	amod	_	_
synovium	NN	I-NP	O	Other	###	12	synovium	synovium	NN	NN	_	9	nmod	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	9	punct	_	_
whereas	IN	O	O	Other	###	14	whereas	whereas	IN	IN	_	9	dep	_	_
the	DT	B-NP	O	Other	###	15	the	the	DT	DT	_	18	det	_	_
T	NN	I-NP	I-protein	B-Protein	###	16	T	T	NN	NN	_	17	nmod:npmod	_	_
cell-derived	NN	I-NP	I-protein	I-Protein	###	17	cell-derived	cell-derived	NN	NN	_	18	amod	_	_
cytokines	NN	I-NP	I-protein	I-Protein	###	18	cytokines	cytokines	NN	NN	_	27	nsubj	_	_
,	,	O	O	Other	###	19	,	,	,	,	_	18	punct	_	_
especially	RB	B-NP	O	Other	###	20	especially	especially	RB	RB	_	21	advmod	_	_
IL-4	NN	I-NP	B-protein	B-Protein	###	21	IL-4	IL-4	NN	NN	_	18	appos	_	_
and	CC	I-NP	O	Other	###	22	and	and	CC	CC	_	21	cc	_	_
interferon-gamma	NN	I-NP	B-protein	B-Protein	###	23	interferon-gamma	interferon-gamma	NN	NN	_	21	conj	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	18	punct	_	_
have	VBP	B-VP	O	Other	###	25	have	have	VBP	VBP	_	27	aux	_	_
often	RB	I-VP	O	Other	###	26	often	often	RB	RB	_	27	advmod	_	_
proved	VBN	I-VP	O	Other	###	27	proved	proved	VBN	VBN	_	9	advcl	_	_
difficult	JJ	B-ADJP	O	Other	###	28	difficult	difficult	JJ	JJ	_	27	xcomp	_	_
to	TO	B-VP	O	Other	###	29	to	to	TO	TO	_	30	mark	_	_
detect	VB	I-VP	O	Other	###	30	detect	detect	VB	VB	_	28	xcomp	_	_
in	IN	B-PP	O	Other	###	31	in	in	IN	IN	_	33	case	_	_
RA	NN	B-NP	O	Other	###	32	RA	RA	NN	NN	_	33	compound	_	_
synovium	NN	I-NP	O	Other	###	33	synovium	synovium	NN	NN	_	30	nmod	_	_
[	(	O	O	Other	###	34	[	[	(	(	_	30	advcl	_	_
24	CD	B-NP	O	Other	###	35	24	24	CD	CD	_	36	nummod	_	_
]	)	O	O	Other	###	36	]	]	)	)	_	34	xcomp	_	_
.	.	O	O	Other	###	37	.	.	.	.	_	9	punct	_	_

Although	IN	B-SBAR	O	Other	###	1	Although	Although	IN	IN	_	5	mark	_	_
T	NN	B-NP	B-cell_type	Other	###	2	T	T	NN	NN	_	3	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	3	cells	cells	NNS	NNS	_	5	nsubj	_	_
may	MD	B-VP	O	Other	###	4	may	may	MD	MD	_	5	aux	_	_
have	VB	I-VP	O	Other	###	5	have	have	VB	VB	_	25	advcl	_	_
a	DT	B-NP	O	Other	###	6	a	a	DT	DT	_	7	det	_	_
role	NN	I-NP	O	Other	###	7	role	role	NN	NN	_	5	dobj	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
augmentation	NN	I-NP	O	Other	###	10	augmentation	augmentation	NN	NN	_	5	nmod	_	_
of	IN	B-PP	O	Other	###	11	of	of	IN	IN	_	14	case	_	_
rheumatoid	JJ	B-NP	O	Other	###	12	rheumatoid	rheumatoid	JJ	JJ	_	14	amod	_	_
synovial	JJ	I-NP	O	Other	###	13	synovial	synovial	JJ	JJ	_	14	amod	_	_
inflammation	NN	I-NP	O	Other	###	14	inflammation	inflammation	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	25	punct	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	17	det	_	_
lack	NN	I-NP	O	Other	###	17	lack	lack	NN	NN	_	25	nsubj	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	23	case	_	_
T	NN	B-NP	B-protein	Other	###	19	T	T	NN	NN	_	23	compound	_	_
cell	JJ	I-NP	I-protein	Other	###	20	cell	cell	JJ	JJ	_	23	compound	_	_
-	-	O	O	Other	###	21	-	-	-	-	_	23	punct	_	_
derived	JJ	I-NP	I-protein	Other	###	22	derived	derived	JJ	JJ	_	23	amod	_	_
cytokines	NNS	I-NP	I-protein	Other	###	23	cytokines	cytokines	NNS	NNS	_	17	nmod	_	_
has	VBZ	B-VP	O	Other	###	24	has	has	VBZ	VBZ	_	25	aux	_	_
limited	VBN	I-VP	O	Other	###	25	limited	limited	VBN	VBN	_	0	root	_	_
its	PRP$	B-NP	O	Other	###	26	its	its	PRP$	PRP$	_	27	nmod:poss	_	_
importance	NN	I-NP	O	Other	###	27	importance	importance	NN	NN	_	25	dobj	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	25	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	3	case	_	_
this	DT	B-NP	O	Other	###	2	this	this	DT	DT	_	3	det	_	_
respect	NN	I-NP	O	Other	###	3	respect	respect	NN	NN	_	7	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	7	punct	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	5	IL-17	IL-17	NN	NN	_	7	nsubj	_	_
is	VBZ	B-VP	O	Other	###	6	is	is	VBZ	VBZ	_	7	cop	_	_
appealing	VBG	I-VP	O	Other	###	7	appealing	appealing	VBG	VBG	_	0	root	_	_
because	IN	B-SBAR	O	Other	###	8	because	because	IN	IN	_	12	mark	_	_
it	PRP	B-NP	O	Other	###	9	it	it	PRP	PRP	_	12	nsubjpass	_	_
has	VBZ	B-VP	O	Other	###	10	has	has	VBZ	VBZ	_	12	aux	_	_
been	VBN	I-VP	O	Other	###	11	been	been	VBN	VBN	_	12	auxpass	_	_
described	VBN	I-VP	O	Other	###	12	described	described	VBN	VBN	_	7	advcl	_	_
as	IN	B-PP	O	Other	###	13	as	as	IN	IN	_	19	case	_	_
a	DT	B-NP	O	Other	###	14	a	a	DT	DT	_	19	det	_	_
T	NN	I-NP	B-protein	Other	###	15	T	T	NN	NN	_	16	compound	_	_
cell	JJ	I-NP	I-protein	Other	###	16	cell	cell	JJ	JJ	_	19	compound	_	_
-	-	O	O	Other	###	17	-	-	-	-	_	19	punct	_	_
derived	JJ	I-NP	I-protein	Other	###	18	derived	derived	JJ	JJ	_	19	amod	_	_
cytokine	NN	I-NP	I-protein	Other	###	19	cytokine	cytokine	NN	NN	_	12	nmod	_	_
with	IN	B-PP	O	Other	###	20	with	with	IN	IN	_	22	case	_	_
proinflammatory	JJ	B-NP	O	Other	###	21	proinflammatory	proinflammatory	JJ	JJ	_	22	amod	_	_
properties	NNS	I-NP	O	Other	###	22	properties	properties	NNS	NNS	_	19	nmod	_	_
.	.	O	O	Other	###	23	.	.	.	.	_	7	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	3	case	_	_
our	PRP$	B-NP	O	Other	###	2	our	our	PRP$	PRP$	_	3	nmod:poss	_	_
studies	NNS	I-NP	O	Other	###	3	studies	studies	NNS	NNS	_	6	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	6	punct	_	_
we	PRP	B-NP	O	Other	###	5	we	we	PRP	PRP	_	6	nsubj	_	_
tried	VBD	B-VP	O	Other	###	6	tried	tried	VBD	VBD	_	0	root	_	_
to	TO	I-VP	O	Other	###	7	to	to	TO	TO	_	8	mark	_	_
evaluate	VB	I-VP	O	Other	###	8	evaluate	evaluate	VB	VB	_	6	xcomp	_	_
how	WRB	B-ADVP	O	Other	###	9	how	how	WRB	WRB	_	13	advmod	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	10	IL-17	IL-17	NN	NN	_	11	compound	_	_
production	NN	I-NP	O	Other	###	11	production	production	NN	NN	_	13	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	12	is	is	VBZ	VBZ	_	13	auxpass	_	_
regulated	VBN	I-VP	O	Other	###	13	regulated	regulated	VBN	VBN	_	8	ccomp	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	16	case	_	_
RA	NN	B-NP	O	Other	###	15	RA	RA	NN	NN	_	16	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	16	PBMC	PBMC	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	13	punct	_	_
and	CC	O	O	Other	###	18	and	and	CC	CC	_	13	cc	_	_
which	WDT	B-NP	O	Other	###	19	which	which	WDT	WDT	_	21	det	_	_
signaling	NN	I-NP	O	Other	###	20	signaling	signaling	NN	NN	_	21	compound	_	_
pathway	NN	I-NP	O	Other	###	21	pathway	pathway	NN	NN	_	23	nsubj	_	_
it	PRP	B-NP	O	Other	###	22	it	it	PRP	PRP	_	23	nsubj	_	_
used	VBD	B-VP	O	Other	###	23	used	used	VBD	VBD	_	8	conj	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	6	punct	_	_

Levels	NNS	B-NP	O	Other	###	1	Levels	Levels	NNS	NNS	_	5	nsubjpass	_	_
of	IN	B-PP	O	Other	###	2	of	of	IN	IN	_	3	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	3	IL-17	IL-17	NN	NN	_	1	nmod	_	_
were	VBD	B-VP	O	Other	###	4	were	were	VBD	VBD	_	5	auxpass	_	_
found	VBN	I-VP	O	Other	###	5	found	found	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	###	6	to	to	TO	TO	_	8	mark	_	_
be	VB	I-VP	O	Other	###	7	be	be	VB	VB	_	8	cop	_	_
higher	JJR	B-ADJP	O	Other	###	8	higher	higher	JJR	JJR	_	5	xcomp	_	_
in	IN	B-PP	O	Other	###	9	in	in	IN	IN	_	12	case	_	_
RA	NN	B-NP	O	Other	###	10	RA	RA	NN	NN	_	12	compound	_	_
synovial	JJ	I-NP	O	Other	###	11	synovial	synovial	JJ	JJ	_	12	amod	_	_
fluid	NN	I-NP	O	Other	###	12	fluid	fluid	NN	NN	_	8	nmod	_	_
than	IN	B-PP	O	Other	###	13	than	than	IN	IN	_	18	mark	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	17	case	_	_
OA	NN	B-NP	O	Other	###	15	OA	OA	NN	NN	_	17	compound	_	_
synovial	JJ	I-NP	O	Other	###	16	synovial	synovial	JJ	JJ	_	17	amod	_	_
fluid	NN	I-NP	O	Other	###	17	fluid	fluid	NN	NN	_	18	nsubj	_	_
[	(	O	O	Other	###	18	[	[	(	(	_	5	advcl	_	_
15	CD	B-NP	O	Other	###	19	15	15	CD	CD	_	20	nummod	_	_
]	)	O	O	Other	###	20	]	]	)	)	_	18	xcomp	_	_
.	.	O	O	Other	###	21	.	.	.	.	_	5	punct	_	_

However	RB	B-ADVP	O	Other	###	1	However	However	RB	RB	_	4	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	4	punct	_	_
there	EX	B-NP	O	Other	###	3	there	there	EX	EX	_	4	expl	_	_
are	VBP	B-VP	O	Other	###	4	are	are	VBP	VBP	_	0	root	_	_
few	JJ	B-NP	O	Other	###	5	few	few	JJ	JJ	_	6	amod	_	_
data	NNS	I-NP	O	Other	###	6	data	data	NNS	NNS	_	4	nsubj	_	_
available	JJ	B-ADJP	O	Other	###	7	available	available	JJ	JJ	_	6	amod	_	_
on	IN	B-PP	O	Other	###	8	on	on	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
agents	NNS	I-NP	O	Other	###	10	agents	agents	NNS	NNS	_	7	nmod	_	_
that	WDT	B-NP	O	Other	###	11	that	that	WDT	WDT	_	12	nsubj	_	_
stimulate	VBP	B-VP	O	Other	###	12	stimulate	stimulate	VBP	VBP	_	10	acl:relcl	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	13	IL-17	IL-17	NN	NN	_	14	compound	_	_
production	NN	I-NP	O	Other	###	14	production	production	NN	NN	_	12	dobj	_	_
in	IN	B-PP	O	Other	###	15	in	in	IN	IN	_	16	case	_	_
RA	NN	B-NP	O	Other	###	16	RA	RA	NN	NN	_	14	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	4	punct	_	_
although	IN	B-SBAR	O	Other	###	18	although	although	IN	IN	_	27	mark	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	21	det	_	_
highest	JJS	I-NP	O	Other	###	20	highest	highest	JJS	JJS	_	21	amod	_	_
level	NN	I-NP	O	Other	###	21	level	level	NN	NN	_	27	nsubjpass	_	_
of	IN	B-PP	O	Other	###	22	of	of	IN	IN	_	24	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	23	IL-17	IL-17	NN	NN	_	24	compound	_	_
production	NN	I-NP	O	Other	###	24	production	production	NN	NN	_	21	nmod	_	_
can	MD	B-VP	O	Other	###	25	can	can	MD	MD	_	27	aux	_	_
be	VB	I-VP	O	Other	###	26	be	be	VB	VB	_	27	auxpass	_	_
achieved	VBN	I-VP	O	Other	###	27	achieved	achieved	VBN	VBN	_	4	advcl	_	_
by	IN	B-PP	O	Other	###	28	by	by	IN	IN	_	34	case	_	_
anti-CD3	NN	B-NP	O	Other	###	29	anti-CD3	anti-CD3	NN	NN	_	34	compound	_	_
/	/	O	O	Other	###	30	/	/	/	/	_	29	punct	_	_
anti	NN	B-NP	O	Other	###	31	anti	anti	NN	NN	_	34	compound	_	_
-	-	O	O	Other	###	32	-	-	-	-	_	31	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	33	CD28	CD28	NN	NN	_	29	dep	_	_
stimulation	NN	I-NP	O	Other	###	34	stimulation	stimulation	NN	NN	_	27	nmod	_	_
in	IN	B-PP	O	Other	###	35	in	in	IN	IN	_	37	case	_	_
healthy	JJ	B-NP	O	Other	###	36	healthy	healthy	JJ	JJ	_	37	amod	_	_
individuals	NNS	I-NP	O	Other	###	37	individuals	individuals	NNS	NNS	_	34	nmod	_	_
[	(	O	O	Other	###	38	[	[	(	(	_	27	advcl	_	_
25	CD	B-NP	O	Other	###	39	25	25	CD	CD	_	40	nummod	_	_
]	)	O	O	Other	###	40	]	]	)	)	_	38	xcomp	_	_
.	.	O	O	Other	###	41	.	.	.	.	_	4	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	3	case	_	_
our	PRP$	B-NP	O	Other	###	2	our	our	PRP$	PRP$	_	3	nmod:poss	_	_
experiments	NNS	I-NP	O	Other	###	3	experiments	experiments	NNS	NNS	_	25	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	25	punct	_	_
PHA	NN	B-NP	B-protein	B-Protein	###	5	PHA	PHA	NN	NN	_	25	nsubj	_	_
as	IN	B-PP	O	Other	###	6	as	as	IN	IN	_	7	case	_	_
mitogens	NNS	B-NP	B-protein	Other	###	7	mitogens	mitogens	NNS	NNS	_	5	nmod	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	5	punct	_	_
as	RB	B-CONJP	O	Other	###	9	as	as	RB	RB	_	5	cc	_	_
well	RB	I-CONJP	O	Other	###	10	well	well	RB	RB	_	9	mwe	_	_
as	IN	I-CONJP	O	Other	###	11	as	as	IN	IN	_	9	mwe	_	_
anti-CD3	NN	B-NP	O	Other	###	12	anti-CD3	anti-CD3	NN	NN	_	5	conj	_	_
/	/	O	O	Other	###	13	/	/	/	/	_	12	punct	_	_
anti	NN	B-NP	O	Other	###	14	anti	anti	NN	NN	_	12	dep	_	_
-	-	O	O	Other	###	15	-	-	-	-	_	14	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	16	CD28	CD28	NN	NN	_	14	dep	_	_
for	IN	B-PP	O	Other	###	17	for	for	IN	IN	_	18	case	_	_
signaling	VBG	B-VP	O	Other	###	18	signaling	signaling	VBG	VBG	_	14	nmod	_	_
through	IN	B-PP	O	Other	###	19	through	through	IN	IN	_	23	case	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	23	det	_	_
T	NN	I-NP	B-protein	Other	###	21	T	T	NN	NN	_	23	compound	_	_
cell	NN	I-NP	I-protein	Other	###	22	cell	cell	NN	NN	_	23	compound	_	_
receptor	NN	I-NP	I-protein	Other	###	23	receptor	receptor	NN	NN	_	18	nmod	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	5	punct	_	_
increased	VBD	B-VP	O	Other	###	25	increased	increased	VBD	VBD	_	0	root	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	26	IL-17	IL-17	NN	NN	_	27	compound	_	_
production	NN	I-NP	O	Other	###	27	production	production	NN	NN	_	25	dobj	_	_
from	IN	B-PP	O	Other	###	28	from	from	IN	IN	_	30	case	_	_
RA	NN	B-NP	O	Other	###	29	RA	RA	NN	NN	_	30	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	30	PBMC	PBMC	NN	NN	_	27	nmod	_	_
in	IN	B-PP	O	Other	###	31	in	in	IN	IN	_	36	case	_	_
a	DT	B-NP	O	Other	###	32	a	a	DT	DT	_	36	det	_	_
dose	JJ	I-NP	O	Other	###	33	dose	dose	JJ	JJ	_	36	amod	_	_
-	-	O	O	Other	###	34	-	-	-	-	_	36	punct	_	_
dependent	JJ	I-NP	O	Other	###	35	dependent	dependent	JJ	JJ	_	33	dep	_	_
manner	NN	I-NP	O	Other	###	36	manner	manner	NN	NN	_	25	nmod	_	_
.	.	O	O	Other	###	37	.	.	.	.	_	25	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
found	VBD	B-VP	O	Other	###	2	found	found	VBD	VBD	_	0	root	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	2	punct	_	_
by	IN	B-PP	O	Other	###	4	by	by	IN	IN	_	8	case	_	_
a	DT	B-NP	O	Other	###	5	a	a	DT	DT	_	8	det	_	_
cell	NN	I-NP	O	Other	###	6	cell	cell	NN	NN	_	8	compound	_	_
proliferation	NN	I-NP	O	Other	###	7	proliferation	proliferation	NN	NN	_	8	compound	_	_
assay	NN	I-NP	O	Other	###	8	assay	assay	NN	NN	_	2	nmod	_	_
(	(	O	O	Other	###	9	(	(	(	(	_	10	punct	_	_
data	NNS	B-NP	O	Other	###	10	data	data	NNS	NNS	_	8	dep	_	_
not	RB	B-VP	O	Other	###	11	not	not	RB	RB	_	12	neg	_	_
shown	VBN	I-VP	O	Other	###	12	shown	shown	VBN	VBN	_	10	acl	_	_
)	)	O	O	Other	###	13	)	)	)	)	_	10	punct	_	_
,	,	O	O	Other	###	14	,	,	,	,	_	2	punct	_	_
that	IN	B-SBAR	O	Other	###	15	that	that	IN	IN	_	26	mark	_	_
this	DT	B-NP	O	Other	###	16	this	this	DT	DT	_	17	det	_	_
upregulation	NN	I-NP	O	Other	###	17	upregulation	upregulation	NN	NN	_	26	nsubj	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	19	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	19	IL-17	IL-17	NN	NN	_	17	nmod	_	_
might	MD	B-VP	O	Other	###	20	might	might	MD	MD	_	26	aux	_	_
be	VB	I-VP	O	Other	###	21	be	be	VB	VB	_	26	cop	_	_
due	JJ	B-PP	O	Other	###	22	due	due	JJ	JJ	_	26	case	_	_
to	TO	B-PP	O	Other	###	23	to	to	TO	TO	_	22	mwe	_	_
increased	VBN	B-NP	O	Other	###	24	increased	increased	VBN	VBN	_	26	amod	_	_
cellular	JJ	I-NP	O	Other	###	25	cellular	cellular	JJ	JJ	_	26	amod	_	_
activity	NN	I-NP	O	Other	###	26	activity	activity	NN	NN	_	2	ccomp	_	_
rather	RB	B-CONJP	O	Other	###	27	rather	rather	RB	RB	_	26	cc	_	_
than	IN	I-CONJP	O	Other	###	28	than	than	IN	IN	_	27	mwe	_	_
to	TO	B-PP	O	Other	###	29	to	to	TO	TO	_	31	case	_	_
cellular	JJ	B-NP	O	Other	###	30	cellular	cellular	JJ	JJ	_	31	amod	_	_
proliferation	NN	I-NP	O	Other	###	31	proliferation	proliferation	NN	NN	_	26	conj	_	_
.	.	O	O	Other	###	32	.	.	.	.	_	2	punct	_	_

IL-17	NN	B-NP	B-protein	B-Protein	###	1	IL-17	IL-17	NN	NN	_	3	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	2	is	is	VBZ	VBZ	_	3	auxpass	_	_
produced	VBN	I-VP	O	Other	###	3	produced	produced	VBN	VBN	_	0	root	_	_
mainly	RB	B-ADVP	O	Other	###	4	mainly	mainly	RB	RB	_	3	advmod	_	_
by	IN	B-PP	O	Other	###	5	by	by	IN	IN	_	7	case	_	_
activated	VBN	B-NP	B-cell_type	Other	###	6	activated	activated	VBN	VBN	_	7	amod	_	_
CD4	NN	B-NP	B-protein	B-Protein	###	7	CD4	CD4	NN	NN	_	3	nmod	_	_
+	+	O	O	Other	###	8	+	+	+	+	_	7	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	9	T	T	NN	NN	_	7	conj	_	_
cells	NNS	I-NP	I-cell_type	Other	###	10	cells	cells	NNS	NNS	_	7	conj	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	3	punct	_	_
especially	RB	B-ADVP	O	Other	###	12	especially	especially	RB	RB	_	17	advmod	_	_
for	IN	B-PP	O	Other	###	13	for	for	IN	IN	_	17	case	_	_
Th1	NN	B-NP	B-cell_line	Other	###	14	Th1	Th1	NN	NN	_	17	compound	_	_
/	/	O	O	Other	###	15	/	/	/	/	_	17	punct	_	_
Th0	NN	B-NP	B-cell_line	Other	###	16	Th0	Th0	NN	NN	_	17	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	17	cells	cells	NNS	NNS	_	3	nmod	_	_
,	,	B-NP	O	Other	###	18	,	,	,	,	_	17	punct	_	_
not	RB	I-NP	O	Other	###	19	not	not	RB	RB	_	22	neg	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	22	det	_	_
Th2	NN	I-NP	O	Other	###	21	Th2	Th2	NN	NN	_	22	compound	_	_
phenotype	NN	I-NP	O	Other	###	22	phenotype	phenotype	NN	NN	_	23	nsubj	_	_
[	(	O	O	Other	###	23	[	[	(	(	_	3	parataxis	_	_
26	CD	B-NP	O	Other	###	24	26	26	CD	CD	_	25	dep	_	_
]	)	O	O	Other	###	25	]	]	)	)	_	23	xcomp	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	3	punct	_	_

However	RB	B-ADVP	O	Other	###	1	However	However	RB	RB	_	7	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	7	punct	_	_
it	PRP	B-NP	O	B-Protein	###	3	it	it	PRP	PRP	_	7	nsubjpass	_	_
can	MD	B-VP	O	Other	###	4	can	can	MD	MD	_	7	aux	_	_
also	RB	I-VP	O	Other	###	5	also	also	RB	RB	_	7	advmod	_	_
be	VB	I-VP	O	Other	###	6	be	be	VB	VB	_	7	auxpass	_	_
produced	VBN	I-VP	O	Other	###	7	produced	produced	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	8	by	by	IN	IN	_	12	case	_	_
CD8	NN	B-NP	B-protein	B-Protein	###	9	CD8	CD8	NN	NN	_	12	compound	_	_
+	+	O	O	Other	###	10	+	+	+	+	_	9	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	11	T	T	NN	NN	_	9	conj	_	_
cells	NNS	I-NP	I-cell_type	Other	###	12	cells	cells	NNS	NNS	_	7	nmod	_	_
via	IN	B-PP	O	Other	###	13	via	via	IN	IN	_	17	case	_	_
an	DT	B-NP	O	Other	###	14	an	an	DT	DT	_	17	det	_	_
IL-23	NN	I-NP	B-protein	B-Protein	###	15	IL-23	IL-23	NN	NN	_	17	compound	_	_
triggering	NN	I-NP	O	Other	###	16	triggering	triggering	NN	NN	_	17	compound	_	_
mechanism	NN	I-NP	O	Other	###	17	mechanism	mechanism	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	18	in	in	IN	IN	_	23	case	_	_
Gram	JJ	B-NP	O	Other	###	19	Gram	Gram	JJ	JJ	_	23	amod	_	_
-	-	O	O	Other	###	20	-	-	-	-	_	23	punct	_	_
negative	JJ	B-NP	O	Other	###	21	negative	negative	JJ	JJ	_	23	amod	_	_
pulmonary	JJ	I-NP	O	Other	###	22	pulmonary	pulmonary	JJ	JJ	_	23	amod	_	_
infection	NN	I-NP	O	Other	###	23	infection	infection	NN	NN	_	17	nmod	_	_
[	(	O	O	Other	###	24	[	[	(	(	_	23	acl	_	_
14	CD	B-NP	O	Other	###	25	14	14	CD	CD	_	26	nummod	_	_
]	)	O	O	Other	###	26	]	]	)	)	_	24	xcomp	_	_
.	.	O	O	Other	###	27	.	.	.	.	_	7	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
addition	NN	B-NP	O	Other	###	2	addition	addition	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	8	punct	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	4	IL-17	IL-17	NN	NN	_	5	compound	_	_
production	NN	I-NP	O	Other	###	5	production	production	NN	NN	_	8	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	6	was	was	VBD	VBD	_	8	auxpass	_	_
significantly	RB	I-VP	O	Other	###	7	significantly	significantly	RB	RB	_	8	advmod	_	_
augmented	VBN	I-VP	O	Other	###	8	augmented	augmented	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	9	by	by	IN	IN	_	11	case	_	_
T	NN	B-NP	B-cell_type	Other	###	10	T	T	NN	NN	_	11	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	11	cells	cells	NNS	NNS	_	8	nmod	_	_
recognizing	VBG	B-VP	O	Other	###	12	recognizing	recognizing	VBG	VBG	_	11	acl	_	_
type	NN	B-NP	B-protein	Other	###	13	type	type	NN	NN	_	15	compound	_	_
II	CD	I-NP	I-protein	Other	###	14	II	II	CD	CD	_	15	nummod	_	_
collagen	NN	I-NP	I-protein	Other	###	15	collagen	collagen	NN	NN	_	12	dobj	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	22	case	_	_
a	DT	B-NP	O	Other	###	17	a	a	DT	DT	_	22	det	_	_
collagen	JJ	I-NP	O	Other	###	18	collagen	collagen	JJ	JJ	_	22	amod	_	_
-	-	O	O	Other	###	19	-	-	-	-	_	22	punct	_	_
induced	JJ	I-NP	O	Other	###	20	induced	induced	JJ	JJ	_	22	amod	_	_
arthritis	NN	I-NP	O	Other	###	21	arthritis	arthritis	NN	NN	_	22	compound	_	_
model	NN	I-NP	O	Other	###	22	model	model	NN	NN	_	15	nmod	_	_
[	(	O	O	Other	###	23	[	[	(	(	_	8	advcl	_	_
27	CD	B-NP	O	Other	###	24	27	27	CD	CD	_	25	nummod	_	_
]	)	O	O	Other	###	25	]	]	)	)	_	23	xcomp	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	8	punct	_	_

A	DT	B-NP	O	Other	###	1	A	A	DT	DT	_	3	det	_	_
complex	JJ	I-NP	O	Other	###	2	complex	complex	JJ	JJ	_	3	amod	_	_
interaction	NN	I-NP	O	Other	###	3	interaction	interaction	NN	NN	_	11	nsubj	_	_
between	IN	B-PP	O	Other	###	4	between	between	IN	IN	_	5	case	_	_
cells	NNS	B-NP	O	Other	###	5	cells	cells	NNS	NNS	_	3	nmod	_	_
in	IN	B-PP	O	Other	###	6	in	in	IN	IN	_	9	case	_	_
inflamed	JJ	B-NP	O	Other	###	7	inflamed	inflamed	JJ	JJ	_	9	amod	_	_
RA	NN	I-NP	O	Other	###	8	RA	RA	NN	NN	_	9	compound	_	_
joints	NNS	I-NP	O	Other	###	9	joints	joints	NNS	NNS	_	5	nmod	_	_
might	MD	B-VP	O	Other	###	10	might	might	MD	MD	_	11	aux	_	_
produce	VB	I-VP	O	Other	###	11	produce	produce	VB	VB	_	0	root	_	_
a	DT	B-NP	O	Other	###	12	a	a	DT	DT	_	13	det	_	_
variety	NN	I-NP	O	Other	###	13	variety	variety	NN	NN	_	11	dobj	_	_
of	IN	B-PP	O	Other	###	14	of	of	IN	IN	_	16	case	_	_
proinflammatory	JJ	B-NP	B-protein	Other	###	15	proinflammatory	proinflammatory	JJ	JJ	_	16	amod	_	_
cytokines	NNS	I-NP	I-protein	Other	###	16	cytokines	cytokines	NNS	NNS	_	13	nmod	_	_
and	CC	I-NP	O	Other	###	17	and	and	CC	CC	_	16	cc	_	_
chemokines	NNS	I-NP	B-protein	Other	###	18	chemokines	chemokines	NNS	NNS	_	16	conj	_	_
,	,	O	O	Other	###	19	,	,	,	,	_	16	punct	_	_
which	WDT	B-NP	O	Other	###	20	which	which	WDT	WDT	_	22	nsubj	_	_
also	RB	B-ADVP	O	Other	###	21	also	also	RB	RB	_	22	advmod	_	_
activate	VBP	B-VP	O	Other	###	22	activate	activate	VBP	VBP	_	16	acl:relcl	_	_
other	JJ	B-NP	O	Other	###	23	other	other	JJ	JJ	_	24	amod	_	_
cells	NNS	I-NP	O	Other	###	24	cells	cells	NNS	NNS	_	22	dobj	_	_
in	IN	B-PP	O	Other	###	25	in	in	IN	IN	_	27	case	_	_
the	DT	B-NP	O	Other	###	26	the	the	DT	DT	_	27	det	_	_
joints	NNS	I-NP	O	Other	###	27	joints	joints	NNS	NNS	_	24	nmod	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	11	punct	_	_

For	IN	B-PP	O	Other	###	1	For	For	IN	IN	_	2	case	_	_
example	NN	B-NP	O	Other	###	2	example	example	NN	NN	_	5	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	5	punct	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	4	IL-17	IL-17	NN	NN	_	5	nsubj	_	_
stimulates	VBZ	B-VP	O	Other	###	5	stimulates	stimulates	VBZ	VBZ	_	0	root	_	_
rheumatoid	JJ	B-NP	B-cell_type	Other	###	6	rheumatoid	rheumatoid	JJ	JJ	_	7	amod	_	_
synoviocytes	NNS	I-NP	I-cell_type	Other	###	7	synoviocytes	synoviocytes	NNS	NNS	_	5	dobj	_	_
to	TO	B-VP	O	Other	###	8	to	to	TO	TO	_	9	mark	_	_
secrete	VB	I-VP	O	Other	###	9	secrete	secrete	VB	VB	_	5	xcomp	_	_
several	JJ	B-NP	O	B-Protein	###	10	several	several	JJ	JJ	_	11	amod	_	_
cytokines	NNS	I-NP	B-protein	I-Protein	###	11	cytokines	cytokines	NNS	NNS	_	9	dobj	_	_
such	JJ	B-PP	O	Other	###	12	such	such	JJ	JJ	_	14	case	_	_
as	IN	I-PP	O	Other	###	13	as	as	IN	IN	_	12	mwe	_	_
IL-6	NN	B-NP	B-protein	B-Protein	###	14	IL-6	IL-6	NN	NN	_	11	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	14	punct	_	_
IL-8	NN	B-NP	B-protein	B-Protein	###	16	IL-8	IL-8	NN	NN	_	14	conj	_	_
and	CC	O	O	Other	###	17	and	and	CC	CC	_	14	cc	_	_
tumor	NN	I-NP	I-protein	B-Protein	###	18	tumor	tumor	NN	NN	_	20	compound	_	_
necrosis	NN	I-NP	I-protein	I-Protein	###	19	necrosis	necrosis	NN	NN	_	20	compound	_	_
factor-stimulated	NN	I-NP	I-protein	I-Protein	###	20	factor-stimulated	factor-stimulated	NN	NN	_	21	compound	_	_
gene	NN	I-NP	I-protein	I-Protein	###	21	gene	gene	NN	NN	_	14	conj	_	_
6	CD	I-NP	I-protein	I-Protein	###	22	6	6	CD	CD	_	21	nummod	_	_
as	RB	B-CONJP	O	Other	###	23	as	as	RB	RB	_	14	cc	_	_
well	RB	I-CONJP	O	Other	###	24	well	well	RB	RB	_	23	mwe	_	_
as	IN	I-CONJP	O	Other	###	25	as	as	IN	IN	_	23	mwe	_	_
prostaglandin	NN	B-NP	O	Other	###	26	prostaglandin	prostaglandin	NN	NN	_	27	compound	_	_
E2	NN	I-NP	O	Other	###	27	E2	E2	NN	NN	_	14	conj	_	_
in	FW	B-NP	O	Other	###	28	in	in	FW	FW	_	29	compound	_	_
vitro	FW	I-NP	O	Other	###	29	vitro	vitro	FW	FW	_	27	advmod	_	_
[	(	I-NP	O	Other	###	30	[	[	(	(	_	5	advcl	_	_
12	CD	I-NP	O	Other	###	31	12	12	CD	CD	_	30	dobj	_	_
,	,	I-NP	O	Other	###	32	,	,	,	,	_	30	punct	_	_
28	CD	I-NP	O	Other	###	33	28	28	CD	CD	_	31	conj	_	_
,	,	I-NP	O	Other	###	34	,	,	,	,	_	31	punct	_	_
29	CD	I-NP	O	Other	###	35	29	29	CD	CD	_	31	nummod	_	_
]	)	O	O	Other	###	36	]	]	)	)	_	30	dobj	_	_
.	.	O	O	Other	###	37	.	.	.	.	_	5	punct	_	_

There	EX	B-NP	O	Other	###	1	There	There	EX	EX	_	2	expl	_	_
are	VBP	B-VP	O	Other	###	2	are	are	VBP	VBP	_	0	root	_	_
as	RB	B-PP	O	Other	###	3	as	as	RB	RB	_	4	advmod	_	_
yet	RB	B-NP	O	Other	###	4	yet	yet	RB	RB	_	5	advmod	_	_
few	JJ	I-NP	O	Other	###	5	few	few	JJ	JJ	_	6	amod	_	_
data	NNS	I-NP	O	Other	###	6	data	data	NNS	NNS	_	2	nsubj	_	_
available	JJ	B-ADJP	O	Other	###	7	available	available	JJ	JJ	_	6	amod	_	_
on	IN	B-PP	O	Other	###	8	on	on	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
agents	NNS	I-NP	O	Other	###	10	agents	agents	NNS	NNS	_	7	nmod	_	_
that	WDT	B-NP	O	Other	###	11	that	that	WDT	WDT	_	12	nsubj	_	_
stimulate	VBP	B-VP	O	Other	###	12	stimulate	stimulate	VBP	VBP	_	10	acl:relcl	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	13	IL-17	IL-17	NN	NN	_	14	compound	_	_
production	NN	I-NP	O	Other	###	14	production	production	NN	NN	_	12	dobj	_	_
in	IN	B-PP	O	Other	###	15	in	in	IN	IN	_	16	case	_	_
RA	NN	B-NP	O	Other	###	16	RA	RA	NN	NN	_	14	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	2	punct	_	_
although	IN	B-SBAR	O	Other	###	18	although	although	IN	IN	_	28	mark	_	_
some	DT	B-NP	O	B-Protein	###	19	some	some	DT	DT	_	20	det	_	_
cytokines	NNS	I-NP	B-protein	I-Protein	###	20	cytokines	cytokines	NNS	NNS	_	28	nsubjpass	_	_
(	(	O	O	Other	###	21	(	(	(	(	_	22	punct	_	_
IL-15	NN	B-NP	B-protein	B-Protein	###	22	IL-15	IL-15	NN	NN	_	20	dep	_	_
and	CC	O	O	Other	###	23	and	and	CC	CC	_	22	cc	_	_
IL-23	NN	B-NP	B-protein	B-Protein	###	24	IL-23	IL-23	NN	NN	_	22	conj	_	_
)	)	O	O	Other	###	25	)	)	)	)	_	22	punct	_	_
have	VBP	B-VP	O	Other	###	26	have	have	VBP	VBP	_	28	aux	_	_
been	VBN	I-VP	O	Other	###	27	been	been	VBN	VBN	_	28	auxpass	_	_
known	VBN	I-VP	O	Other	###	28	known	known	VBN	VBN	_	2	advcl	_	_
to	TO	I-VP	O	Other	###	29	to	to	TO	TO	_	30	mark	_	_
regulate	VB	I-VP	O	Other	###	30	regulate	regulate	VB	VB	_	28	xcomp	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	31	IL-17	IL-17	NN	NN	_	32	compound	_	_
production	NN	I-NP	O	Other	###	32	production	production	NN	NN	_	30	dobj	_	_
[	(	O	O	Other	###	33	[	[	(	(	_	30	xcomp	_	_
13	CD	B-NP	O	Other	###	34	13	13	CD	CD	_	33	dobj	_	_
,	,	I-NP	O	Other	###	35	,	,	,	,	_	33	punct	_	_
14	CD	I-NP	O	Other	###	36	14	14	CD	CD	_	37	nummod	_	_
]	)	O	O	Other	###	37	]	]	)	)	_	33	xcomp	_	_
.	.	O	O	Other	###	38	.	.	.	.	_	2	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	3	nsubj	_	_
therefore	RB	B-ADVP	O	Other	###	2	therefore	therefore	RB	RB	_	3	advmod	_	_
investigated	VBD	B-VP	O	Other	###	3	investigated	investigated	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	7	det	_	_
in	FW	I-NP	O	Other	###	5	in	in	FW	FW	_	7	amod	_	_
vitro	FW	I-NP	O	Other	###	6	vitro	vitro	FW	FW	_	5	dep	_	_
production	NN	I-NP	O	Other	###	7	production	production	NN	NN	_	3	dobj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	9	IL-17	IL-17	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	10	in	in	IN	IN	_	12	case	_	_
RA	NN	B-NP	O	Other	###	11	RA	RA	NN	NN	_	12	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	12	PBMC	PBMC	NN	NN	_	7	nmod	_	_
responding	VBG	B-VP	O	Other	###	13	responding	responding	VBG	VBG	_	12	acl	_	_
to	TO	B-PP	O	Other	###	14	to	to	TO	TO	_	16	case	_	_
a	DT	B-NP	O	Other	###	15	a	a	DT	DT	_	16	det	_	_
variety	NN	I-NP	O	Other	###	16	variety	variety	NN	NN	_	13	nmod	_	_
of	IN	B-PP	O	Other	###	17	of	of	IN	IN	_	18	case	_	_
cytokines	NNS	B-NP	B-protein	Other	###	18	cytokines	cytokines	NNS	NNS	_	16	nmod	_	_
/	/	O	O	Other	###	19	/	/	/	/	_	18	punct	_	_
chemokines	NNS	B-NP	B-protein	Other	###	20	chemokines	chemokines	NNS	NNS	_	18	dep	_	_
and	CC	I-NP	O	Other	###	21	and	and	CC	CC	_	20	cc	_	_
mitogens	NNS	I-NP	B-protein	Other	###	22	mitogens	mitogens	NNS	NNS	_	20	conj	_	_
as	RB	B-CONJP	O	Other	###	23	as	as	RB	RB	_	18	cc	_	_
well	RB	I-CONJP	O	Other	###	24	well	well	RB	RB	_	23	mwe	_	_
as	IN	I-CONJP	O	Other	###	25	as	as	IN	IN	_	23	mwe	_	_
T	NN	B-NP	B-protein	Other	###	26	T	T	NN	NN	_	28	compound	_	_
cell	NN	I-NP	I-protein	Other	###	27	cell	cell	NN	NN	_	28	compound	_	_
receptor	NN	I-NP	I-protein	Other	###	28	receptor	receptor	NN	NN	_	32	compound	_	_
(	(	O	O	Other	###	29	(	(	(	(	_	30	punct	_	_
TCR	NN	B-NP	B-protein	Other	###	30	TCR	TCR	NN	NN	_	28	appos	_	_
)	)	O	O	Other	###	31	)	)	)	)	_	30	punct	_	_
ligation	NN	B-NP	O	Other	###	32	ligation	ligation	NN	NN	_	16	conj	_	_
using	VBG	B-VP	O	Other	###	33	using	using	VBG	VBG	_	32	acl	_	_
anti-CD3	NN	B-NP	O	Other	###	34	anti-CD3	anti-CD3	NN	NN	_	33	dobj	_	_
/	/	O	O	Other	###	35	/	/	/	/	_	34	punct	_	_
anti	NN	B-NP	O	Other	###	36	anti	anti	NN	NN	_	34	dep	_	_
-	-	O	O	Other	###	37	-	-	-	-	_	34	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	38	CD28	CD28	NN	NN	_	34	dep	_	_
.	.	O	O	Other	###	39	.	.	.	.	_	3	punct	_	_

Our	PRP$	B-NP	O	Other	###	1	Our	Our	PRP$	PRP$	_	2	nmod:poss	_	_
studies	NNS	I-NP	O	Other	###	2	studies	studies	NNS	NNS	_	3	nsubj	_	_
demonstrated	VBD	B-VP	O	Other	###	3	demonstrated	demonstrated	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	14	mark	_	_
IL-15	NN	B-NP	B-protein	B-Protein	###	5	IL-15	IL-15	NN	NN	_	14	nsubj	_	_
and	CC	I-NP	O	Other	###	6	and	and	CC	CC	_	5	cc	_	_
MCP-1	NN	I-NP	B-protein	B-Protein	###	7	MCP-1	MCP-1	NN	NN	_	5	conj	_	_
as	RB	B-CONJP	O	Other	###	8	as	as	RB	RB	_	5	cc	_	_
well	RB	I-CONJP	O	Other	###	9	well	well	RB	RB	_	8	mwe	_	_
as	IN	I-CONJP	O	Other	###	10	as	as	IN	IN	_	8	mwe	_	_
TCR	NN	B-NP	B-protein	Other	###	11	TCR	TCR	NN	NN	_	12	compound	_	_
ligation	NN	I-NP	O	Other	###	12	ligation	ligation	NN	NN	_	5	conj	_	_
significantly	RB	B-ADVP	O	Other	###	13	significantly	significantly	RB	RB	_	14	advmod	_	_
increased	VBD	B-VP	O	Other	###	14	increased	increased	VBD	VBD	_	3	ccomp	_	_
the	DT	B-NP	O	Other	###	15	the	the	DT	DT	_	16	det	_	_
production	NN	I-NP	O	Other	###	16	production	production	NN	NN	_	14	dobj	_	_
of	IN	B-PP	O	Other	###	17	of	of	IN	IN	_	18	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	18	IL-17	IL-17	NN	NN	_	16	nmod	_	_
in	IN	B-PP	O	Other	###	19	in	in	IN	IN	_	21	case	_	_
RA	NN	B-NP	O	Other	###	20	RA	RA	NN	NN	_	21	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	21	PBMC	PBMC	NN	NN	_	16	nmod	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	3	punct	_	_

Adding	VBG	B-VP	O	Other	###	1	Adding	Adding	VBG	VBG	_	8	csubj	_	_
IL-15	NN	B-NP	B-protein	B-Protein	###	2	IL-15	IL-15	NN	NN	_	1	dobj	_	_
or	CC	I-NP	O	Other	###	3	or	or	CC	CC	_	2	cc	_	_
MCP-1	NN	I-NP	B-protein	B-Protein	###	4	MCP-1	MCP-1	NN	NN	_	2	conj	_	_
to	TO	B-PP	O	Other	###	5	to	to	TO	TO	_	7	case	_	_
TCR	NN	B-NP	B-protein	Other	###	6	TCR	TCR	NN	NN	_	7	compound	_	_
ligation	NN	I-NP	O	Other	###	7	ligation	ligation	NN	NN	_	1	nmod	_	_
augmented	VBD	B-VP	O	Other	###	8	augmented	augmented	VBD	VBD	_	0	root	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	9	IL-17	IL-17	NN	NN	_	10	compound	_	_
production	NN	I-NP	O	Other	###	10	production	production	NN	NN	_	8	dobj	_	_
more	RBR	B-ADVP	O	Other	###	11	more	more	RBR	RBR	_	12	advmod	_	_
markedly	RB	I-ADVP	O	Other	###	12	markedly	markedly	RB	RB	_	8	advmod	_	_
.	.	O	O	Other	###	13	.	.	.	.	_	8	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
contrast	NN	B-NP	O	Other	###	2	contrast	contrast	NN	NN	_	25	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	25	punct	_	_
IL-1	NN	B-NP	B-protein	B-Protein	###	4	IL-1	IL-1	NN	NN	_	25	nsubj	_	_
and	CC	I-NP	O	Other	###	5	and	and	CC	CC	_	4	cc	_	_
TNF-alpha	NN	I-NP	B-protein	B-Protein	###	6	TNF-alpha	TNF-alpha	NN	NN	_	4	conj	_	_
,	,	O	O	Other	###	7	,	,	,	,	_	4	punct	_	_
which	WDT	B-NP	O	B-Protein	###	8	which	which	WDT	WDT	_	10	nsubjpass	_	_
are	VBP	B-VP	O	Other	###	9	are	are	VBP	VBP	_	10	auxpass	_	_
known	VBN	I-VP	O	Other	###	10	known	known	VBN	VBN	_	4	acl:relcl	_	_
to	TO	I-VP	O	Other	###	11	to	to	TO	TO	_	12	mark	_	_
have	VB	I-VP	O	Other	###	12	have	have	VB	VB	_	10	ccomp	_	_
proinflammatory	JJ	B-NP	O	Other	###	13	proinflammatory	proinflammatory	JJ	JJ	_	14	amod	_	_
properties	NNS	I-NP	O	Other	###	14	properties	properties	NNS	NNS	_	12	dobj	_	_
and	CC	O	O	Other	###	15	and	and	CC	CC	_	12	cc	_	_
to	TO	B-VP	O	Other	###	16	to	to	TO	TO	_	18	mark	_	_
be	VB	I-VP	O	Other	###	17	be	be	VB	VB	_	18	auxpass	_	_
increased	VBN	I-VP	O	Other	###	18	increased	increased	VBN	VBN	_	12	conj	_	_
in	IN	B-PP	O	Other	###	19	in	in	IN	IN	_	21	case	_	_
RA	NN	B-NP	O	Other	###	20	RA	RA	NN	NN	_	21	compound	_	_
joints	NNS	I-NP	O	Other	###	21	joints	joints	NNS	NNS	_	18	nmod	_	_
,	,	O	O	Other	###	22	,	,	,	,	_	4	punct	_	_
did	VBD	B-VP	O	Other	###	23	did	did	VBD	VBD	_	25	aux	_	_
not	RB	I-VP	O	Other	###	24	not	not	RB	RB	_	25	neg	_	_
affect	VB	I-VP	O	Other	###	25	affect	affect	VB	VB	_	0	root	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	26	IL-17	IL-17	NN	NN	_	27	compound	_	_
production	NN	I-NP	O	Other	###	27	production	production	NN	NN	_	25	dobj	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	25	punct	_	_

Our	PRP$	B-NP	O	Other	###	1	Our	Our	PRP$	PRP$	_	2	nmod:poss	_	_
data	NNS	I-NP	O	Other	###	2	data	data	NNS	NNS	_	4	nsubj	_	_
were	VBD	B-VP	O	Other	###	3	were	were	VBD	VBD	_	4	cop	_	_
consistent	JJ	B-ADJP	O	Other	###	4	consistent	consistent	JJ	JJ	_	0	root	_	_
with	IN	B-PP	O	Other	###	5	with	with	IN	IN	_	8	case	_	_
a	DT	B-NP	O	Other	###	6	a	a	DT	DT	_	8	det	_	_
recent	JJ	I-NP	O	Other	###	7	recent	recent	JJ	JJ	_	8	amod	_	_
report	NN	I-NP	O	Other	###	8	report	report	NN	NN	_	4	nmod	_	_
that	IN	B-SBAR	O	Other	###	9	that	that	IN	IN	_	11	mark	_	_
IL-15	NN	B-NP	B-protein	B-Protein	###	10	IL-15	IL-15	NN	NN	_	11	nsubj	_	_
triggered	VBD	B-VP	O	Other	###	11	triggered	triggered	VBD	VBD	_	8	ccomp	_	_
in	FW	B-NP	O	Other	###	12	in	in	FW	FW	_	15	amod	_	_
vitro	FW	I-NP	O	Other	###	13	vitro	vitro	FW	FW	_	12	dep	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	14	IL-17	IL-17	NN	NN	_	15	compound	_	_
production	NN	I-NP	O	Other	###	15	production	production	NN	NN	_	11	dobj	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	17	case	_	_
PBMC	NN	B-NP	B-cell_type	Other	###	17	PBMC	PBMC	NN	NN	_	15	nmod	_	_
,	,	O	O	Other	###	18	,	,	,	,	_	11	punct	_	_
but	CC	O	O	Other	###	19	but	but	CC	CC	_	11	cc	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	###	20	TNF-alpha	TNF-alpha	NN	NN	_	25	nsubj	_	_
did	VBD	B-VP	O	Other	###	21	did	did	VBD	VBD	_	25	aux	_	_
not	RB	I-VP	O	Other	###	22	not	not	RB	RB	_	25	neg	_	_
do	VB	I-VP	O	Other	###	23	do	do	VB	VB	_	25	aux	_	_
so	RB	B-ADVP	O	Other	###	24	so	so	RB	RB	_	25	advmod	_	_
[	(	O	O	Other	###	25	[	[	(	(	_	11	conj	_	_
13	CD	B-NP	O	Other	###	26	13	13	CD	CD	_	27	nummod	_	_
]	)	O	O	Other	###	27	]	]	)	)	_	25	xcomp	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	4	punct	_	_

Although	IN	B-SBAR	O	Other	###	1	Although	Although	IN	IN	_	3	mark	_	_
there	EX	B-NP	O	Other	###	2	there	there	EX	EX	_	3	expl	_	_
were	VBD	B-VP	O	Other	###	3	were	were	VBD	VBD	_	16	advcl	_	_
no	DT	B-NP	O	Other	###	4	no	no	DT	DT	_	5	neg	_	_
data	NNS	I-NP	O	Other	###	5	data	data	NNS	NNS	_	3	nsubj	_	_
that	IN	B-SBAR	O	Other	###	6	that	that	IN	IN	_	9	mark	_	_
MCP-1	NN	B-NP	B-protein	B-Protein	###	7	MCP-1	MCP-1	NN	NN	_	9	nsubj	_	_
directly	RB	B-ADVP	O	Other	###	8	directly	directly	RB	RB	_	9	advmod	_	_
induces	VBZ	B-VP	O	Other	###	9	induces	induces	VBZ	VBZ	_	5	ccomp	_	_
T	NN	B-NP	O	Other	###	10	T	T	NN	NN	_	12	compound	_	_
cell	NN	I-NP	O	Other	###	11	cell	cell	NN	NN	_	12	compound	_	_
activation	NN	I-NP	O	Other	###	12	activation	activation	NN	NN	_	9	dobj	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	16	punct	_	_
it	PRP	B-NP	O	B-Protein	###	14	it	it	PRP	PRP	_	16	nsubj	_	_
might	MD	B-VP	O	Other	###	15	might	might	MD	MD	_	16	aux	_	_
exert	VB	I-VP	O	Other	###	16	exert	exert	VB	VB	_	0	root	_	_
effects	NNS	B-NP	O	Other	###	17	effects	effects	NNS	NNS	_	16	dobj	_	_
indirectly	RB	B-ADVP	O	Other	###	18	indirectly	indirectly	RB	RB	_	16	advmod	_	_
on	IN	B-PP	O	Other	###	19	on	on	IN	IN	_	21	case	_	_
T	NN	B-NP	B-cell_type	Other	###	20	T	T	NN	NN	_	21	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	21	cells	cells	NNS	NNS	_	16	nmod	_	_
through	IN	B-PP	O	Other	###	22	through	through	IN	IN	_	24	case	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	24	det	_	_
activation	NN	I-NP	O	Other	###	24	activation	activation	NN	NN	_	16	nmod	_	_
of	IN	B-PP	O	Other	###	25	of	of	IN	IN	_	26	case	_	_
monocytes	NNS	B-NP	B-cell_type	Other	###	26	monocytes	monocytes	NNS	NNS	_	24	nmod	_	_
/	/	O	O	Other	###	27	/	/	/	/	_	26	punct	_	_
macrophages	NNS	B-NP	B-cell_type	Other	###	28	macrophages	macrophages	NNS	NNS	_	26	dep	_	_
in	IN	B-PP	O	Other	###	29	in	in	IN	IN	_	31	case	_	_
PBMC	NN	B-NP	B-cell_type	Other	###	30	PBMC	PBMC	NN	NN	_	31	compound	_	_
cultures	NNS	I-NP	O	Other	###	31	cultures	cultures	NNS	NNS	_	24	nmod	_	_
.	.	O	O	Other	###	32	.	.	.	.	_	16	punct	_	_

As	IN	B-SBAR	O	Other	###	1	As	As	IN	IN	_	2	mark	_	_
reported	VBN	B-VP	O	Other	###	2	reported	reported	VBN	VBN	_	20	advcl	_	_
for	IN	B-PP	O	Other	###	3	for	for	IN	IN	_	5	case	_	_
normal	JJ	B-NP	O	Other	###	4	normal	normal	JJ	JJ	_	5	amod	_	_
individuals	NNS	I-NP	O	Other	###	5	individuals	individuals	NNS	NNS	_	2	nmod	_	_
[	(	O	O	Other	###	6	[	[	(	(	_	2	advcl	_	_
25	CD	B-NP	O	Other	###	7	25	25	CD	CD	_	8	nummod	_	_
]	)	O	O	Other	###	8	]	]	)	)	_	6	dobj	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	20	punct	_	_
T	NN	B-NP	O	Other	###	10	T	T	NN	NN	_	12	compound	_	_
cell	NN	I-NP	O	Other	###	11	cell	cell	NN	NN	_	12	compound	_	_
activation	NN	I-NP	O	Other	###	12	activation	activation	NN	NN	_	20	nsubj	_	_
through	IN	B-PP	O	Other	###	13	through	through	IN	IN	_	14	case	_	_
anti-CD3	NN	B-NP	O	Other	###	14	anti-CD3	anti-CD3	NN	NN	_	12	nmod	_	_
/	/	O	O	Other	###	15	/	/	/	/	_	16	punct	_	_
anti	NN	B-NP	O	Other	###	16	anti	anti	NN	NN	_	14	dep	_	_
-	-	O	O	Other	###	17	-	-	-	-	_	16	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	18	CD28	CD28	NN	NN	_	16	dep	_	_
also	RB	B-ADVP	O	Other	###	19	also	also	RB	RB	_	20	advmod	_	_
increases	VBZ	B-VP	O	Other	###	20	increases	increases	VBZ	VBZ	_	0	root	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	21	IL-17	IL-17	NN	NN	_	22	compound	_	_
induction	NN	I-NP	O	Other	###	22	induction	induction	NN	NN	_	20	dobj	_	_
in	IN	B-PP	O	Other	###	23	in	in	IN	IN	_	25	case	_	_
RA	NN	B-NP	B-cell_type	Other	###	24	RA	RA	NN	NN	_	25	compound	_	_
PBMC	NN	I-NP	I-cell_type	Other	###	25	PBMC	PBMC	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	20	punct	_	_

Although	IN	B-SBAR	O	Other	###	1	Although	Although	IN	IN	_	16	mark	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	4	det	_	_
signaling	NN	I-NP	O	Other	###	3	signaling	signaling	NN	NN	_	4	compound	_	_
pathway	NN	I-NP	O	Other	###	4	pathway	pathway	NN	NN	_	16	nsubjpass	_	_
for	IN	B-PP	O	Other	###	5	for	for	IN	IN	_	7	case	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	7	det	_	_
induction	NN	I-NP	O	Other	###	7	induction	induction	NN	NN	_	4	nmod	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
cytokines	NNS	B-NP	B-protein	Other	###	9	cytokines	cytokines	NNS	NNS	_	7	nmod	_	_
/	/	O	O	Other	###	10	/	/	/	/	_	9	punct	_	_
chemokines	NNS	B-NP	B-protein	Other	###	11	chemokines	chemokines	NNS	NNS	_	9	dep	_	_
by	IN	B-PP	O	Other	###	12	by	by	IN	IN	_	13	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	13	IL-17	IL-17	NN	NN	_	7	nmod	_	_
has	VBZ	B-VP	O	Other	###	14	has	has	VBZ	VBZ	_	16	aux	_	_
been	VBN	I-VP	O	Other	###	15	been	been	VBN	VBN	_	16	auxpass	_	_
documented	VBN	I-VP	O	Other	###	16	documented	documented	VBN	VBN	_	30	advcl	_	_
widely	RB	B-NP	O	Other	###	17	widely	widely	RB	RB	_	18	advmod	_	_
[	(	I-NP	O	Other	###	18	[	[	(	(	_	16	xcomp	_	_
8	CD	I-NP	O	Other	###	19	8	8	CD	CD	_	18	dobj	_	_
,	,	I-NP	O	Other	###	20	,	,	,	,	_	19	punct	_	_
30	CD	I-NP	O	Other	###	21	30	30	CD	CD	_	19	conj	_	_
,	,	I-NP	O	Other	###	22	,	,	,	,	_	19	punct	_	_
31	CD	I-NP	O	Other	###	23	31	31	CD	CD	_	19	conj	_	_
]	)	O	O	Other	###	24	]	]	)	)	_	18	dobj	_	_
,	,	O	O	Other	###	25	,	,	,	,	_	30	punct	_	_
no	DT	B-NP	O	Other	###	26	no	no	DT	DT	_	27	neg	_	_
data	NNS	I-NP	O	Other	###	27	data	data	NNS	NNS	_	30	nsubj	_	_
have	VBP	B-VP	O	Other	###	28	have	have	VBP	VBP	_	30	aux	_	_
been	VBN	I-VP	O	Other	###	29	been	been	VBN	VBN	_	30	cop	_	_
available	JJ	B-ADJP	O	Other	###	30	available	available	JJ	JJ	_	0	root	_	_
on	IN	B-PP	O	Other	###	31	on	on	IN	IN	_	37	mark	_	_
how	WRB	B-ADVP	O	Other	###	32	how	how	WRB	WRB	_	37	advmod	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	33	IL-17	IL-17	NN	NN	_	34	compound	_	_
production	NN	I-NP	O	Other	###	34	production	production	NN	NN	_	37	nsubjpass	_	_
can	MD	B-VP	O	Other	###	35	can	can	MD	MD	_	37	aux	_	_
be	VB	I-VP	O	Other	###	36	be	be	VB	VB	_	37	auxpass	_	_
regulated	VBN	I-VP	O	Other	###	37	regulated	regulated	VBN	VBN	_	30	advcl	_	_
by	IN	B-PP	O	Other	###	38	by	by	IN	IN	_	41	case	_	_
certain	JJ	B-NP	O	Other	###	39	certain	certain	JJ	JJ	_	41	amod	_	_
signaling	NN	I-NP	O	Other	###	40	signaling	signaling	NN	NN	_	41	compound	_	_
pathways	NNS	I-NP	O	Other	###	41	pathways	pathways	NNS	NNS	_	37	nmod	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	30	punct	_	_

By	IN	B-PP	O	Other	###	1	By	By	IN	IN	_	2	mark	_	_
using	VBG	B-VP	O	Other	###	2	using	using	VBG	VBG	_	9	advcl	_	_
signal	NN	B-NP	B-protein	Other	###	3	signal	signal	NN	NN	_	5	compound	_	_
transduction	NN	I-NP	I-protein	Other	###	4	transduction	transduction	NN	NN	_	5	compound	_	_
inhibitors	NNS	I-NP	I-protein	Other	###	5	inhibitors	inhibitors	NNS	NNS	_	2	dobj	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	9	punct	_	_
we	PRP	B-NP	O	Other	###	7	we	we	PRP	PRP	_	9	nsubj	_	_
therefore	RB	B-ADVP	O	Other	###	8	therefore	therefore	RB	RB	_	9	advmod	_	_
examined	VBD	B-VP	O	Other	###	9	examined	examined	VBD	VBD	_	0	root	_	_
which	WDT	B-NP	O	Other	###	10	which	which	WDT	WDT	_	12	det	_	_
signaling	NN	I-NP	O	Other	###	11	signaling	signaling	NN	NN	_	12	compound	_	_
pathway	NN	I-NP	O	Other	###	12	pathway	pathway	NN	NN	_	15	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	13	was	was	VBD	VBD	_	15	auxpass	_	_
mainly	RB	I-VP	O	Other	###	14	mainly	mainly	RB	RB	_	15	advmod	_	_
involved	VBN	I-VP	O	Other	###	15	involved	involved	VBN	VBN	_	9	ccomp	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	18	case	_	_
the	DT	B-NP	O	Other	###	17	the	the	DT	DT	_	18	det	_	_
induction	NN	I-NP	O	Other	###	18	induction	induction	NN	NN	_	15	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	20	IL-17	IL-17	NN	NN	_	18	nmod	_	_
in	IN	B-PP	O	Other	###	21	in	in	IN	IN	_	23	case	_	_
RA	NN	B-NP	O	Other	###	22	RA	RA	NN	NN	_	23	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	23	PBMC	PBMC	NN	NN	_	18	nmod	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	9	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
identified	VBD	B-VP	O	Other	###	2	identified	identified	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	3	that	that	IN	IN	_	16	mark	_	_
anti	NN	B-NP	O	Other	###	4	anti	anti	NN	NN	_	8	nmod:npmod	_	_
-	-	O	O	Other	###	5	-	-	-	-	_	8	punct	_	_
CD3	NN	B-NP	B-protein	B-Protein	###	6	CD3	CD3	NN	NN	_	8	nmod:npmod	_	_
-	-	O	O	Other	###	7	-	-	-	-	_	8	punct	_	_
induced	NN	O	O	Other	###	8	induced	induced	NN	NN	_	10	amod	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	9	IL-17	IL-17	NN	NN	_	10	compound	_	_
production	NN	I-NP	O	Other	###	10	production	production	NN	NN	_	16	nsubjpass	_	_
in	IN	B-PP	O	Other	###	11	in	in	IN	IN	_	13	case	_	_
RA	NN	B-NP	O	Other	###	12	RA	RA	NN	NN	_	13	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	13	PBMC	PBMC	NN	NN	_	10	nmod	_	_
was	VBD	B-VP	O	Other	###	14	was	was	VBD	VBD	_	16	auxpass	_	_
significantly	RB	I-VP	O	Other	###	15	significantly	significantly	RB	RB	_	16	advmod	_	_
hampered	VBN	I-VP	O	Other	###	16	hampered	hampered	VBN	VBN	_	2	ccomp	_	_
by	IN	B-PP	O	Other	###	17	by	by	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	###	18	the	the	DT	DT	_	21	det	_	_
PI3K	NN	I-NP	B-protein	Other	###	19	PI3K	PI3K	NN	NN	_	21	compound	_	_
inhibitor	NN	I-NP	O	Other	###	20	inhibitor	inhibitor	NN	NN	_	21	compound	_	_
LY294002	NN	I-NP	O	Other	###	21	LY294002	LY294002	NN	NN	_	16	nmod	_	_
and	CC	O	O	Other	###	22	and	and	CC	CC	_	21	cc	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	26	det	_	_
NF-kappaB	NN	I-NP	B-protein	Other	###	24	NF-kappaB	NF-kappaB	NN	NN	_	26	compound	_	_
inhibitor	NN	I-NP	O	Other	###	25	inhibitor	inhibitor	NN	NN	_	26	compound	_	_
PDTC	NN	I-NP	O	Other	###	26	PDTC	PDTC	NN	NN	_	21	conj	_	_
to	TO	B-PP	O	Other	###	27	to	to	TO	TO	_	29	case	_	_
comparable	JJ	B-NP	O	Other	###	28	comparable	comparable	JJ	JJ	_	29	amod	_	_
levels	NNS	I-NP	O	Other	###	29	levels	levels	NNS	NNS	_	16	nmod	_	_
of	IN	B-PP	O	Other	###	30	of	of	IN	IN	_	32	case	_	_
basal	JJ	B-NP	O	Other	###	31	basal	basal	JJ	JJ	_	32	amod	_	_
production	NN	I-NP	O	Other	###	32	production	production	NN	NN	_	29	nmod	_	_
without	IN	B-PP	O	Other	###	33	without	without	IN	IN	_	34	case	_	_
stimulation	NN	B-NP	O	Other	###	34	stimulation	stimulation	NN	NN	_	32	nmod	_	_
.	.	O	O	Other	###	35	.	.	.	.	_	2	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	3	nsubj	_	_
also	RB	B-ADVP	O	Other	###	2	also	also	RB	RB	_	3	advmod	_	_
found	VBD	B-VP	O	Other	###	3	found	found	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	11	mark	_	_
anti-CD3	JJ	B-NP	O	Other	###	5	anti-CD3	anti-CD3	JJ	JJ	_	9	amod	_	_
-	-	O	O	Other	###	6	-	-	-	-	_	7	punct	_	_
induced	JJ	B-NP	O	Other	###	7	induced	induced	JJ	JJ	_	9	amod	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	8	IL-17	IL-17	NN	NN	_	9	compound	_	_
production	NN	I-NP	O	Other	###	9	production	production	NN	NN	_	11	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	10	was	was	VBD	VBD	_	11	auxpass	_	_
downregulated	VBN	I-VP	O	Other	###	11	downregulated	downregulated	VBN	VBN	_	3	ccomp	_	_
by	IN	B-PP	O	Other	###	12	by	by	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	###	13	the	the	DT	DT	_	14	det	_	_
addition	NN	I-NP	O	Other	###	14	addition	addition	NN	NN	_	11	nmod	_	_
of	IN	B-PP	O	Other	###	15	of	of	IN	IN	_	16	case	_	_
SB203580	NN	B-NP	O	Other	###	16	SB203580	SB203580	NN	NN	_	14	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	16	punct	_	_
a	DT	B-NP	O	Other	###	18	a	a	DT	DT	_	21	det	_	_
p38	NN	I-NP	B-protein	Other	###	19	p38	p38	NN	NN	_	21	compound	_	_
MAPK	NN	I-NP	I-protein	Other	###	20	MAPK	MAPK	NN	NN	_	21	compound	_	_
inhibitor	NN	I-NP	O	Other	###	21	inhibitor	inhibitor	NN	NN	_	16	appos	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	3	punct	_	_

It	PRP	B-NP	O	Other	###	1	It	It	PRP	PRP	_	3	nsubj	_	_
is	VBZ	B-VP	O	Other	###	2	is	is	VBZ	VBZ	_	3	cop	_	_
interesting	JJ	B-ADJP	O	Other	###	3	interesting	interesting	JJ	JJ	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	9	mark	_	_
a	DT	B-NP	O	Other	###	5	a	a	DT	DT	_	6	det	_	_
series	NN	I-NP	O	Other	###	6	series	series	NN	NN	_	9	nsubj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	8	case	_	_
evidence	NN	B-NP	O	Other	###	8	evidence	evidence	NN	NN	_	6	nmod	_	_
supports	VBZ	B-VP	O	Other	###	9	supports	supports	VBZ	VBZ	_	3	ccomp	_	_
crosstalk	NN	B-NP	O	Other	###	10	crosstalk	crosstalk	NN	NN	_	9	dobj	_	_
between	IN	B-PP	O	Other	###	11	between	between	IN	IN	_	12	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	12	NF-kappaB	NF-kappaB	NN	NN	_	10	nmod	_	_
and	CC	I-NP	O	Other	###	13	and	and	CC	CC	_	12	cc	_	_
p38	NN	I-NP	B-protein	Other	###	14	p38	p38	NN	NN	_	12	conj	_	_
.	.	O	O	Other	###	15	.	.	.	.	_	3	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
myocytes	NNS	B-NP	O	Other	###	2	myocytes	myocytes	NNS	NNS	_	7	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	7	punct	_	_
IkappaB	NN	B-NP	B-protein	B-Protein	###	4	IkappaB	IkappaB	NN	NN	_	5	compound	_	_
kinase-beta	NN	I-NP	I-protein	I-Protein	###	5	kinase-beta	kinase-beta	NN	NN	_	7	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	6	is	is	VBZ	VBZ	_	7	auxpass	_	_
activated	VBN	I-VP	O	Other	###	7	activated	activated	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	8	by	by	IN	IN	_	9	case	_	_
p38	NN	B-NP	B-protein	Other	###	9	p38	p38	NN	NN	_	7	nmod	_	_
[	(	O	O	Other	###	10	[	[	(	(	_	7	dep	_	_
32	CD	B-NP	O	Other	###	11	32	32	CD	CD	_	12	nummod	_	_
]	)	O	O	Other	###	12	]	]	)	)	_	7	advcl	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	7	punct	_	_
and	CC	O	O	Other	###	14	and	and	CC	CC	_	7	cc	_	_
the	DT	B-NP	O	Other	###	15	the	the	DT	DT	_	17	det	_	_
activated	VBN	I-NP	O	Other	###	16	activated	activated	VBN	VBN	_	17	amod	_	_
p38	NN	I-NP	B-protein	Other	###	17	p38	p38	NN	NN	_	19	nsubj	_	_
can	MD	B-VP	O	Other	###	18	can	can	MD	MD	_	19	aux	_	_
stimulate	VB	I-VP	O	Other	###	19	stimulate	stimulate	VB	VB	_	7	conj	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	20	NF-kappaB	NF-kappaB	NN	NN	_	19	dobj	_	_
by	IN	B-PP	O	Other	###	21	by	by	IN	IN	_	23	case	_	_
a	DT	B-NP	O	Other	###	22	a	a	DT	DT	_	23	det	_	_
mechanism	NN	I-NP	O	Other	###	23	mechanism	mechanism	NN	NN	_	19	nmod	_	_
involving	VBG	B-VP	O	Other	###	24	involving	involving	VBG	VBG	_	23	acl	_	_
histone	NN	B-NP	B-protein	Other	###	25	histone	histone	NN	NN	_	30	compound	_	_
acetylase	NN	I-NP	I-protein	Other	###	26	acetylase	acetylase	NN	NN	_	30	compound	_	_
p300	NN	B-NP	B-protein	B-Protein	###	27	p300	p300	NN	NN	_	30	compound	_	_
/	/	O	O	Other	###	28	/	/	/	/	_	30	punct	_	_
CREB-binding	NN	I-NP	I-protein	B-Protein	###	29	CREB-binding	CREB-binding	NN	NN	_	30	compound	_	_
protein	NN	I-NP	I-protein	I-Protein	###	30	protein	protein	NN	NN	_	24	dobj	_	_
[	(	O	O	Other	###	31	[	[	(	(	_	30	acl	_	_
33	CD	B-NP	O	Other	###	32	33	33	CD	CD	_	33	nummod	_	_
]	)	O	O	Other	###	33	]	]	)	)	_	31	xcomp	_	_
.	.	O	O	Other	###	34	.	.	.	.	_	7	punct	_	_

Our	PRP$	B-NP	O	Other	###	1	Our	Our	PRP$	PRP$	_	2	nmod:poss	_	_
results	NNS	I-NP	O	Other	###	2	results	results	NNS	NNS	_	3	nsubj	_	_
revealed	VBD	B-VP	O	Other	###	3	revealed	revealed	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	10	mark	_	_
p38	NN	B-NP	B-protein	Other	###	5	p38	p38	NN	NN	_	7	compound	_	_
MAPK	NN	I-NP	I-protein	Other	###	6	MAPK	MAPK	NN	NN	_	7	compound	_	_
activation	NN	I-NP	O	Other	###	7	activation	activation	NN	NN	_	10	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	8	was	was	VBD	VBD	_	10	auxpass	_	_
not	RB	I-VP	O	Other	###	9	not	not	RB	RB	_	10	neg	_	_
affected	VBN	I-VP	O	Other	###	10	affected	affected	VBN	VBN	_	3	ccomp	_	_
by	IN	B-PP	O	Other	###	11	by	by	IN	IN	_	12	case	_	_
LY294002	NN	B-NP	O	Other	###	12	LY294002	LY294002	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	10	punct	_	_
whereas	IN	O	O	Other	###	14	whereas	whereas	IN	IN	_	10	dep	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	15	NF-kappaB	NF-kappaB	NN	NN	_	17	compound	_	_
binding	NN	I-NP	O	Other	###	16	binding	binding	NN	NN	_	17	compound	_	_
activity	NN	I-NP	O	Other	###	17	activity	activity	NN	NN	_	19	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	18	was	was	VBD	VBD	_	19	auxpass	_	_
decreased	VBN	I-VP	O	Other	###	19	decreased	decreased	VBN	VBN	_	10	parataxis	_	_
by	IN	B-PP	O	Other	###	20	by	by	IN	IN	_	21	case	_	_
LY294002	NN	B-NP	O	Other	###	21	LY294002	LY294002	NN	NN	_	19	nmod	_	_
,	,	O	O	Other	###	22	,	,	,	,	_	19	punct	_	_
which	WDT	B-NP	O	Other	###	23	which	which	WDT	WDT	_	24	nsubj	_	_
provided	VBD	B-VP	O	Other	###	24	provided	provided	VBD	VBD	_	19	ccomp	_	_
the	DT	B-NP	O	Other	###	25	the	the	DT	DT	_	26	det	_	_
evidence	NN	I-NP	O	Other	###	26	evidence	evidence	NN	NN	_	24	dobj	_	_
for	IN	B-PP	O	Other	###	27	for	for	IN	IN	_	31	case	_	_
a	DT	B-NP	O	Other	###	28	a	a	DT	DT	_	31	det	_	_
p38	NN	I-NP	B-protein	Other	###	29	p38	p38	NN	NN	_	31	compound	_	_
MAPK	NN	I-NP	I-protein	Other	###	30	MAPK	MAPK	NN	NN	_	31	compound	_	_
pathway	NN	I-NP	O	Other	###	31	pathway	pathway	NN	NN	_	26	nmod	_	_
independent	JJ	B-ADJP	O	Other	###	32	independent	independent	JJ	JJ	_	31	amod	_	_
of	IN	B-PP	O	Other	###	33	of	of	IN	IN	_	35	case	_	_
PI3K	NN	B-NP	B-protein	Other	###	34	PI3K	PI3K	NN	NN	_	35	compound	_	_
activation	NN	I-NP	O	Other	###	35	activation	activation	NN	NN	_	32	nmod	_	_
.	.	O	O	Other	###	36	.	.	.	.	_	3	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	3	det	_	_
direct	JJ	I-NP	O	Other	###	2	direct	direct	JJ	JJ	_	3	amod	_	_
relationship	NN	I-NP	O	Other	###	3	relationship	relationship	NN	NN	_	11	nsubj	_	_
between	IN	B-PP	O	Other	###	4	between	between	IN	IN	_	5	case	_	_
p38	NN	B-NP	B-protein	Other	###	5	p38	p38	NN	NN	_	3	nmod	_	_
and	CC	I-NP	O	Other	###	6	and	and	CC	CC	_	5	cc	_	_
NF-kappaB	NN	I-NP	B-protein	Other	###	7	NF-kappaB	NF-kappaB	NN	NN	_	5	conj	_	_
for	IN	B-PP	O	Other	###	8	for	for	IN	IN	_	10	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	9	IL-17	IL-17	NN	NN	_	10	compound	_	_
production	NN	I-NP	O	Other	###	10	production	production	NN	NN	_	3	nmod	_	_
needs	VBZ	B-VP	O	Other	###	11	needs	needs	VBZ	VBZ	_	0	root	_	_
to	TO	I-VP	O	Other	###	12	to	to	TO	TO	_	14	mark	_	_
be	VB	I-VP	O	Other	###	13	be	be	VB	VB	_	14	auxpass	_	_
studied	VBN	I-VP	O	Other	###	14	studied	studied	VBN	VBN	_	11	xcomp	_	_
in	IN	B-PP	O	Other	###	15	in	in	IN	IN	_	17	case	_	_
future	JJ	B-NP	O	Other	###	16	future	future	JJ	JJ	_	17	amod	_	_
experiments	NNS	I-NP	O	Other	###	17	experiments	experiments	NNS	NNS	_	14	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	11	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
search	NN	I-NP	O	Other	###	2	search	search	NN	NN	_	9	nsubj	_	_
for	IN	B-PP	O	Other	###	3	for	for	IN	IN	_	6	case	_	_
a	DT	B-NP	O	Other	###	4	a	a	DT	DT	_	6	det	_	_
downstream	JJ	I-NP	O	Other	###	5	downstream	downstream	JJ	JJ	_	6	amod	_	_
pathway	NN	I-NP	O	Other	###	6	pathway	pathway	NN	NN	_	2	nmod	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	8	case	_	_
PI3K	NN	B-NP	B-protein	Other	###	8	PI3K	PI3K	NN	NN	_	6	nmod	_	_
seemed	VBD	B-VP	O	Other	###	9	seemed	seemed	VBD	VBD	_	0	root	_	_
to	TO	I-VP	O	Other	###	10	to	to	TO	TO	_	11	mark	_	_
have	VB	I-VP	O	Other	###	11	have	have	VB	VB	_	9	xcomp	_	_
a	DT	B-NP	O	Other	###	12	a	a	DT	DT	_	14	det	_	_
maximal	JJ	I-NP	O	Other	###	13	maximal	maximal	JJ	JJ	_	14	amod	_	_
response	NN	I-NP	O	Other	###	14	response	response	NN	NN	_	11	dobj	_	_
of	IN	B-PP	O	Other	###	15	of	of	IN	IN	_	17	case	_	_
Akt	NN	B-NP	B-protein	B-Protein	###	16	Akt	Akt	NN	NN	_	17	compound	_	_
activation	NN	I-NP	O	Other	###	17	activation	activation	NN	NN	_	14	nmod	_	_
at	IN	B-PP	O	Other	###	18	at	at	IN	IN	_	20	case	_	_
1	CD	B-NP	O	Other	###	19	1	1	CD	CD	_	20	nummod	_	_
hour	NN	I-NP	O	Other	###	20	hour	hour	NN	NN	_	14	nmod	_	_
and	CC	O	O	Other	###	21	and	and	CC	CC	_	14	cc	_	_
a	DT	B-NP	O	Other	###	22	a	a	DT	DT	_	24	det	_	_
gradual	JJ	I-NP	O	Other	###	23	gradual	gradual	JJ	JJ	_	24	amod	_	_
loss	NN	I-NP	O	Other	###	24	loss	loss	NN	NN	_	14	conj	_	_
of	IN	B-PP	O	Other	###	25	of	of	IN	IN	_	26	case	_	_
activity	NN	B-NP	O	Other	###	26	activity	activity	NN	NN	_	24	nmod	_	_
at	IN	B-PP	O	Other	###	27	at	at	IN	IN	_	29	case	_	_
2	CD	B-NP	O	Other	###	28	2	2	CD	CD	_	29	nummod	_	_
hours	NNS	I-NP	O	Other	###	29	hours	hours	NNS	NNS	_	24	nmod	_	_
.	.	O	O	Other	###	30	.	.	.	.	_	9	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
fact	NN	I-NP	O	Other	###	2	fact	fact	NN	NN	_	10	nsubj	_	_
that	IN	B-SBAR	O	Other	###	3	that	that	IN	IN	_	6	mark	_	_
Akt	NN	B-NP	B-protein	B-Protein	###	4	Akt	Akt	NN	NN	_	6	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	5	is	is	VBZ	VBZ	_	6	auxpass	_	_
phosphorylated	VBN	I-VP	O	Other	###	6	phosphorylated	phosphorylated	VBN	VBN	_	2	ccomp	_	_
upon	IN	B-PP	O	Other	###	7	upon	upon	IN	IN	_	9	case	_	_
anti-CD3	JJ	B-NP	B-protein	Other	###	8	anti-CD3	anti-CD3	JJ	JJ	_	9	amod	_	_
stimulation	NN	I-NP	O	Other	###	9	stimulation	stimulation	NN	NN	_	6	nmod	_	_
suggests	VBZ	B-VP	O	Other	###	10	suggests	suggests	VBZ	VBZ	_	0	root	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	13	det	_	_
possible	JJ	I-NP	O	Other	###	12	possible	possible	JJ	JJ	_	13	amod	_	_
involvement	NN	I-NP	O	Other	###	13	involvement	involvement	NN	NN	_	10	dobj	_	_
of	IN	B-PP	O	Other	###	14	of	of	IN	IN	_	15	case	_	_
PI3K	NN	B-NP	B-protein	Other	###	15	PI3K	PI3K	NN	NN	_	13	nmod	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	18	case	_	_
the	DT	B-NP	O	Other	###	17	the	the	DT	DT	_	18	det	_	_
induction	NN	I-NP	O	Other	###	18	induction	induction	NN	NN	_	13	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	20	IL-17	IL-17	NN	NN	_	18	nmod	_	_
in	IN	B-PP	O	Other	###	21	in	in	IN	IN	_	22	case	_	_
RA	NN	B-NP	O	Other	###	22	RA	RA	NN	NN	_	18	nmod	_	_
.	.	O	O	Other	###	23	.	.	.	.	_	10	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
view	NN	B-NP	O	Other	###	2	view	view	NN	NN	_	28	nmod	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	5	case	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	5	det	_	_
fact	NN	I-NP	O	Other	###	5	fact	fact	NN	NN	_	2	nmod	_	_
that	IN	B-SBAR	O	Other	###	6	that	that	IN	IN	_	10	mark	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	7	NF-kappaB	NF-kappaB	NN	NN	_	10	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	8	was	was	VBD	VBD	_	10	auxpass	_	_
also	RB	I-VP	O	Other	###	9	also	also	RB	RB	_	10	advmod	_	_
activated	VBN	I-VP	O	Other	###	10	activated	activated	VBN	VBN	_	5	ccomp	_	_
by	IN	B-PP	O	Other	###	11	by	by	IN	IN	_	12	case	_	_
anti-CD3	NN	B-NP	O	Other	###	12	anti-CD3	anti-CD3	NN	NN	_	10	nmod	_	_
/	/	O	O	Other	###	13	/	/	/	/	_	14	punct	_	_
anti	NN	B-NP	O	Other	###	14	anti	anti	NN	NN	_	10	nmod	_	_
-	-	O	O	Other	###	15	-	-	-	-	_	14	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	16	CD28	CD28	NN	NN	_	14	dep	_	_
,	,	I-NP	O	Other	###	17	,	,	,	,	_	14	punct	_	_
IL-15	NN	I-NP	B-protein	B-Protein	###	18	IL-15	IL-15	NN	NN	_	14	conj	_	_
or	CC	I-NP	O	Other	###	19	or	or	CC	CC	_	14	cc	_	_
mitogens	NNS	I-NP	B-protein	Other	###	20	mitogens	mitogens	NNS	NNS	_	14	conj	_	_
in	IN	B-PP	O	Other	###	21	in	in	IN	IN	_	23	case	_	_
our	PRP$	B-NP	O	Other	###	22	our	our	PRP$	PRP$	_	23	nmod:poss	_	_
experiments	NNS	I-NP	O	Other	###	23	experiments	experiments	NNS	NNS	_	10	nmod	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	28	punct	_	_
it	PRP	B-NP	O	Other	###	25	it	it	PRP	PRP	_	28	nsubj	_	_
is	VBZ	B-VP	O	Other	###	26	is	is	VBZ	VBZ	_	28	cop	_	_
most	RBS	B-ADJP	O	Other	###	27	most	most	RBS	RBS	_	28	advmod	_	_
likely	JJ	I-ADJP	O	Other	###	28	likely	likely	JJ	JJ	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	29	that	that	IN	IN	_	36	mark	_	_
the	DT	B-NP	O	Other	###	30	the	the	DT	DT	_	32	det	_	_
NF-kappaB	NN	I-NP	B-protein	Other	###	31	NF-kappaB	NF-kappaB	NN	NN	_	32	compound	_	_
pathway	NN	I-NP	O	Other	###	32	pathway	pathway	NN	NN	_	36	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	33	is	is	VBZ	VBZ	_	36	auxpass	_	_
also	RB	B-ADVP	O	Other	###	34	also	also	RB	RB	_	36	advmod	_	_
actively	RB	B-ADJP	O	Other	###	35	actively	actively	RB	RB	_	36	advmod	_	_
involved	VBN	I-ADJP	O	Other	###	36	involved	involved	VBN	VBN	_	28	ccomp	_	_
in	IN	B-PP	O	Other	###	37	in	in	IN	IN	_	39	case	_	_
the	DT	B-NP	O	Other	###	38	the	the	DT	DT	_	39	det	_	_
induction	NN	I-NP	O	Other	###	39	induction	induction	NN	NN	_	36	nmod	_	_
of	IN	B-PP	O	Other	###	40	of	of	IN	IN	_	41	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	41	IL-17	IL-17	NN	NN	_	39	nmod	_	_
in	IN	B-PP	O	Other	###	42	in	in	IN	IN	_	44	case	_	_
RA	NN	B-NP	O	Other	###	43	RA	RA	NN	NN	_	44	compound	_	_
PBMC	NN	I-NP	B-cell_type	Other	###	44	PBMC	PBMC	NN	NN	_	39	nmod	_	_
.	.	O	O	Other	###	45	.	.	.	.	_	28	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
contrast	NN	B-NP	O	Other	###	2	contrast	contrast	NN	NN	_	21	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	21	punct	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	8	det	_	_
AP-1	NN	I-NP	B-protein	B-Protein	###	5	AP-1	AP-1	NN	NN	_	8	compound	_	_
signal	NN	I-NP	O	Other	###	6	signal	signal	NN	NN	_	8	compound	_	_
transduction	NN	I-NP	O	Other	###	7	transduction	transduction	NN	NN	_	8	compound	_	_
pathway	NN	I-NP	O	Other	###	8	pathway	pathway	NN	NN	_	21	nsubjpass	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	8	punct	_	_
another	DT	B-NP	O	Other	###	10	another	another	DT	DT	_	13	det	_	_
important	JJ	I-NP	O	Other	###	11	important	important	JJ	JJ	_	13	amod	_	_
signaling	NN	I-NP	O	Other	###	12	signaling	signaling	NN	NN	_	13	compound	_	_
pathway	NN	I-NP	O	Other	###	13	pathway	pathway	NN	NN	_	8	appos	_	_
for	IN	B-PP	O	Other	###	14	for	for	IN	IN	_	15	case	_	_
cytokines	NNS	B-NP	B-protein	Other	###	15	cytokines	cytokines	NNS	NNS	_	13	nmod	_	_
/	/	O	O	Other	###	16	/	/	/	/	_	15	punct	_	_
chemokines	NNS	B-NP	B-protein	Other	###	17	chemokines	chemokines	NNS	NNS	_	13	nmod	_	_
,	,	O	O	Other	###	18	,	,	,	,	_	8	punct	_	_
was	VBD	B-VP	O	Other	###	19	was	was	VBD	VBD	_	21	auxpass	_	_
not	RB	I-VP	O	Other	###	20	not	not	RB	RB	_	21	neg	_	_
activated	VBN	I-VP	O	Other	###	21	activated	activated	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	22	in	in	IN	IN	_	24	case	_	_
our	PRP$	B-NP	O	Other	###	23	our	our	PRP$	PRP$	_	24	nmod:poss	_	_
experiments	NNS	I-NP	O	Other	###	24	experiments	experiments	NNS	NNS	_	21	nmod	_	_
(	(	O	O	Other	###	25	(	(	(	(	_	26	punct	_	_
data	NNS	B-NP	O	Other	###	26	data	data	NNS	NNS	_	24	dep	_	_
not	RB	B-VP	O	Other	###	27	not	not	RB	RB	_	28	neg	_	_
shown	VBN	I-VP	O	Other	###	28	shown	shown	VBN	VBN	_	26	acl	_	_
)	)	O	O	Other	###	29	)	)	)	)	_	26	punct	_	_
.	.	O	O	Other	###	30	.	.	.	.	_	21	punct	_	_

Although	IN	B-SBAR	O	Other	###	1	Although	Although	IN	IN	_	14	mark	_	_
PI3K	NN	B-NP	B-protein	Other	###	2	PI3K	PI3K	NN	NN	_	14	nsubjpass	_	_
and	CC	O	O	Other	###	3	and	and	CC	CC	_	2	cc	_	_
its	PRP$	B-NP	O	Other	###	4	its	its	PRP$	PRP$	_	7	nmod:poss	_	_
downstream	JJ	I-NP	O	Other	###	5	downstream	downstream	JJ	JJ	_	7	amod	_	_
kinase	NN	I-NP	O	Other	###	6	kinase	kinase	NN	NN	_	7	compound	_	_
Akt	NN	I-NP	O	B-Protein	###	7	Akt	Akt	NN	NN	_	2	conj	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	9	case	_	_
association	NN	B-NP	O	Other	###	9	association	association	NN	NN	_	2	nmod	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	11	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	11	NF-kappaB	NF-kappaB	NN	NN	_	9	nmod	_	_
have	VBP	B-VP	O	Other	###	12	have	have	VBP	VBP	_	14	aux	_	_
been	VBN	I-VP	O	Other	###	13	been	been	VBN	VBN	_	14	auxpass	_	_
reported	VBN	I-VP	O	Other	###	14	reported	reported	VBN	VBN	_	32	advcl	_	_
to	TO	I-VP	O	Other	###	15	to	to	TO	TO	_	16	mark	_	_
deliver	VB	I-VP	O	Other	###	16	deliver	deliver	VB	VB	_	14	xcomp	_	_
activating	VBG	B-NP	O	Other	###	17	activating	activating	VBG	VBG	_	18	amod	_	_
signals	NNS	I-NP	O	Other	###	18	signals	signals	NNS	NNS	_	16	dobj	_	_
in	IN	B-PP	O	Other	###	19	in	in	IN	IN	_	22	case	_	_
many	JJ	B-NP	O	Other	###	20	many	many	JJ	JJ	_	22	amod	_	_
cell	NN	I-NP	O	Other	###	21	cell	cell	NN	NN	_	22	compound	_	_
types	NNS	I-NP	O	Other	###	22	types	types	NNS	NNS	_	16	nmod	_	_
,	,	O	O	Other	###	23	,	,	,	,	_	32	punct	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	25	det	_	_
data	NNS	I-NP	O	Other	###	25	data	data	NNS	NNS	_	32	nsubjpass	_	_
on	IN	B-PP	O	Other	###	26	on	on	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	27	the	the	DT	DT	_	28	det	_	_
signal	NN	I-NP	O	Other	###	28	signal	signal	NN	NN	_	25	nmod	_	_
inducing	VBG	B-VP	O	Other	###	29	inducing	inducing	VBG	VBG	_	28	acl	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	30	IL-17	IL-17	NN	NN	_	29	dobj	_	_
are	VBP	B-VP	O	Other	###	31	are	are	VBP	VBP	_	32	auxpass	_	_
lacking	VBG	I-VP	O	Other	###	32	lacking	lacking	VBG	VBG	_	0	root	_	_
.	.	O	O	Other	###	33	.	.	.	.	_	32	punct	_	_

Our	PRP$	B-NP	O	Other	###	1	Our	Our	PRP$	PRP$	_	2	nmod:poss	_	_
data	NNS	I-NP	O	Other	###	2	data	data	NNS	NNS	_	4	nsubj	_	_
clearly	RB	B-VP	O	Other	###	3	clearly	clearly	RB	RB	_	4	advmod	_	_
demonstrated	VBD	I-VP	O	Other	###	4	demonstrated	demonstrated	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	5	that	that	IN	IN	_	17	mark	_	_
PI3K	NN	B-NP	O	Other	###	6	PI3K	PI3K	NN	NN	_	17	nsubj	_	_
/	/	O	O	Other	###	7	/	/	/	/	_	8	punct	_	_
Akt	NN	B-NP	B-protein	B-Protein	###	8	Akt	Akt	NN	NN	_	12	amod	_	_
and	CC	O	O	Other	###	9	and	and	CC	CC	_	8	cc	_	_
resultant	JJ	B-NP	O	Other	###	10	resultant	resultant	JJ	JJ	_	12	amod	_	_
NF-kappaB	NN	I-NP	B-protein	Other	###	11	NF-kappaB	NF-kappaB	NN	NN	_	12	compound	_	_
activation	NN	I-NP	O	Other	###	12	activation	activation	NN	NN	_	6	conj	_	_
could	MD	B-VP	O	Other	###	13	could	could	MD	MD	_	17	aux	_	_
be	VB	I-VP	O	Other	###	14	be	be	VB	VB	_	17	cop	_	_
an	DT	B-NP	O	Other	###	15	an	an	DT	DT	_	17	det	_	_
important	JJ	I-NP	O	Other	###	16	important	important	JJ	JJ	_	17	amod	_	_
arbitrator	NN	I-NP	O	Other	###	17	arbitrator	arbitrator	NN	NN	_	4	ccomp	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
upregulation	NN	I-NP	O	Other	###	20	upregulation	upregulation	NN	NN	_	17	nmod	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	22	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	22	IL-17	IL-17	NN	NN	_	20	nmod	_	_
in	IN	B-PP	O	Other	###	23	in	in	IN	IN	_	24	case	_	_
RA	NN	B-NP	O	Other	###	24	RA	RA	NN	NN	_	20	nmod	_	_
,	,	O	O	Other	###	25	,	,	,	,	_	17	punct	_	_
on	IN	B-PP	O	Other	###	26	on	on	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	27	the	the	DT	DT	_	28	det	_	_
basis	NN	I-NP	O	Other	###	28	basis	basis	NN	NN	_	17	nmod	_	_
of	IN	B-PP	O	Other	###	29	of	of	IN	IN	_	31	case	_	_
our	PRP$	B-NP	O	Other	###	30	our	our	PRP$	PRP$	_	31	nmod:poss	_	_
experiments	NNS	I-NP	O	Other	###	31	experiments	experiments	NNS	NNS	_	28	nmod	_	_
showing	VBG	B-VP	O	Other	###	32	showing	showing	VBG	VBG	_	31	acl	_	_
simultaneous	JJ	B-NP	O	Other	###	33	simultaneous	simultaneous	JJ	JJ	_	34	amod	_	_
blocking	NN	I-NP	O	Other	###	34	blocking	blocking	NN	NN	_	32	dobj	_	_
of	IN	B-PP	O	Other	###	35	of	of	IN	IN	_	38	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	###	36	NF-kappaB	NF-kappaB	NN	NN	_	38	compound	_	_
binding	NN	I-NP	O	Other	###	37	binding	binding	NN	NN	_	38	compound	_	_
activity	NN	I-NP	O	Other	###	38	activity	activity	NN	NN	_	34	nmod	_	_
in	IN	B-PP	O	Other	###	39	in	in	IN	IN	_	42	case	_	_
the	DT	B-NP	O	Other	###	40	the	the	DT	DT	_	42	det	_	_
IL-17	NN	I-NP	B-DNA	B-Protein	###	41	IL-17	IL-17	NN	NN	_	42	compound	_	_
promoter	NN	I-NP	I-DNA	Other	###	42	promoter	promoter	NN	NN	_	38	nmod	_	_
by	IN	B-PP	O	Other	###	43	by	by	IN	IN	_	44	case	_	_
PDTC	NN	B-NP	O	Other	###	44	PDTC	PDTC	NN	NN	_	34	nmod	_	_
and	CC	I-NP	O	Other	###	45	and	and	CC	CC	_	44	cc	_	_
LY294002	NN	I-NP	O	Other	###	46	LY294002	LY294002	NN	NN	_	44	conj	_	_
.	.	O	O	Other	###	47	.	.	.	.	_	4	punct	_	_

Considering	VBG	B-VP	O	Other	###	1	Considering	Considering	VBG	VBG	_	24	advcl	_	_
its	PRP$	B-NP	O	Other	###	2	its	its	PRP$	PRP$	_	4	nmod:poss	_	_
proinflammatory	JJ	I-NP	O	Other	###	3	proinflammatory	proinflammatory	JJ	JJ	_	4	amod	_	_
activities	NNS	I-NP	O	Other	###	4	activities	activities	NNS	NNS	_	1	dobj	_	_
and	CC	O	O	Other	###	5	and	and	CC	CC	_	4	cc	_	_
successful	JJ	B-NP	O	Other	###	6	successful	successful	JJ	JJ	_	7	amod	_	_
induction	NN	I-NP	O	Other	###	7	induction	induction	NN	NN	_	4	conj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
anti	NN	B-NP	O	Other	###	9	anti	anti	NN	NN	_	7	nmod	_	_
-	-	O	O	Other	###	10	-	-	-	-	_	9	punct	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	11	IL-17	IL-17	NN	NN	_	9	dep	_	_
for	IN	B-PP	O	Other	###	12	for	for	IN	IN	_	14	case	_	_
ameliorating	VBG	B-VP	O	Other	###	13	ameliorating	ameliorating	VBG	VBG	_	14	amod	_	_
arthritis	NN	B-NP	O	Other	###	14	arthritis	arthritis	NN	NN	_	7	nmod	_	_
in	IN	B-PP	O	Other	###	15	in	in	IN	IN	_	17	case	_	_
animal	NN	B-NP	O	Other	###	16	animal	animal	NN	NN	_	17	compound	_	_
models	NNS	I-NP	O	Other	###	17	models	models	NNS	NNS	_	14	nmod	_	_
[	(	O	O	Other	###	18	[	[	(	(	_	1	parataxis	_	_
2	CD	B-NP	O	Other	###	19	2	2	CD	CD	_	18	dobj	_	_
,	,	I-NP	O	Other	###	20	,	,	,	,	_	19	punct	_	_
6	CD	I-NP	O	Other	###	21	6	6	CD	CD	_	19	amod	_	_
,	,	I-NP	O	Other	###	22	,	,	,	,	_	19	punct	_	_
34-36	CD	I-NP	O	Other	###	23	34-36	34-36	CD	CD	_	19	amod	_	_
]	)	O	O	Other	###	24	]	]	)	)	_	0	root	_	_
,	,	O	O	Other	###	25	,	,	,	,	_	1	punct	_	_
understanding	VBG	B-VP	O	Other	###	26	understanding	understanding	VBG	VBG	_	1	parataxis	_	_
the	DT	B-NP	O	Other	###	27	the	the	DT	DT	_	30	det	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	28	IL-17	IL-17	NN	NN	_	30	compound	_	_
signaling	NN	I-NP	O	Other	###	29	signaling	signaling	NN	NN	_	30	compound	_	_
pathway	NN	I-NP	O	Other	###	30	pathway	pathway	NN	NN	_	26	dobj	_	_
is	VBZ	B-VP	O	Other	###	31	is	is	VBZ	VBZ	_	34	cop	_	_
an	DT	B-NP	O	Other	###	32	an	an	DT	DT	_	34	det	_	_
important	JJ	I-NP	O	Other	###	33	important	important	JJ	JJ	_	34	amod	_	_
element	NN	I-NP	O	Other	###	34	element	element	NN	NN	_	26	ccomp	_	_
of	IN	B-PP	O	Other	###	35	of	of	IN	IN	_	36	mark	_	_
developing	VBG	B-VP	O	Other	###	36	developing	developing	VBG	VBG	_	34	acl	_	_
new	JJ	B-NP	O	Other	###	37	new	new	JJ	JJ	_	39	amod	_	_
targeted	VBN	I-NP	O	Other	###	38	targeted	targeted	VBN	VBN	_	39	amod	_	_
therapies	NNS	I-NP	O	Other	###	39	therapies	therapies	NNS	NNS	_	36	dobj	_	_
in	IN	B-PP	O	Other	###	40	in	in	IN	IN	_	41	case	_	_
RA	NN	B-NP	O	Other	###	41	RA	RA	NN	NN	_	39	nmod	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	1	punct	_	_

